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ABSTRACT 
 BACKGROUND & OBJECTIVES: Abnormal uterine bleeding is the 
most common complaint in gynaecology and an important source of 
morbidity. This study evaluates the role of diagnostic hysteroscopy in the 
evaluation of Abnormal Uterine Bleeding in women of reproductive age 
group and its histopathological correlation. 
 METHODS: 50 patients with AUB who got admitted at Coimbatore 
Medical College Hospital in the Department of Obstetrics and 
Gynaecology were subjected to hysteroscopy and endometrial sampling. 
Histopathological analysis of the endometrial sample obtained. The 
hysteroscopic findings were correlated with the histopathology report. 
 RESULTS: AUB was more common in 40-49 yrs. The most common 
presenting complaint was Menorrhagia. Hysteroscopy was done 
successfully in all the patients. Abnormalities seen were endometrial 
hyperplasia (simple and complex), submucous myoma, and atrophic 
endometrium, proliferative phase and secretory phase. Hysteroscopy was 
found to be 100% sensitive and specific in diagnosis of endometrial 
lesions. The positive predictive value was 100% for hysteroscopy in 
diagnosis of endometrial lesions. 
 CONCLUSION: This study confirms the conclusion of many others that 
hysteroscopy is an accurate and a feasible investigation in evaluating 
patients with Abnormal Uterine Bleeding. 
 Keywords: Hysteroscopy, D&C, Abnormal Uterine Bleeding, 
Histopathology. 
CONTENTS 
SERIAL 
NO. TITLE PAGE NO. 
1 INTRODUCTION 1 
2 AIM AND OBJECTIVE 4 
3 REVIEW OF LITERATURE 5 
4 MATERIALS AND METHODS 38 
5 RESULTS AND OBSERVATION 43 
6 DISCUSSION 58 
7 SUMMARY 73 
8 CONCLUSION 76 
9 BIBILIOGRAPHY  
10 ANNEXURE 
¾ ABBREVIATIONS 
¾ PROFORMA 
¾ CONSENT FORM 
¾ MASTERCHART 
 
 
  
LIST OF TABLES 
S. 
NO. LIST OF TABLES 
PAGE 
NO 
1 STRUCTURAL CAUSES OF AUB 8 
2 CAUSES OF AUB IN REPRODUCTIVE AGE WOMEN 9 
3 CAUSES OF AUB IN PERIMENOPAUSAL WOMEN 10 
4 CLASSIFICATION OF ENDOMETRIAL 
HYPERPLASIA 
11 
5 COMPLAINTS OF PATIENTS.  43 
6 DISTRIBUTION OF GRAVIDOUS WOMEN. 44 
7 AGE DISTRIBUTION OF PATIENTS WITH  
ABNORMAL UTERINE BLEEDING.  
46 
8 HYSTEROSCOPIC FINDINGS. 49 
9 DURATION  OF  PATIENTS SYMPTOMS  
10 HISTOPATHOLOGICAL FINDINGS. 54 
11 HYPERPLASIA IN HPE 56 
12 SENSITIVITY, SPECIFICITY, POSITIVE 
PREDICTIVE VALUE AND NEGATIVE PREDICTIVE 
VALUE OF HYSTEROSCOPY WITH HPE 
57 
13 SENSITIVITY AND SPECIFICITY PLOT AND 
POOLED RESULTS OF DIAGNOSTIC 
HYSTEROSCOPY IN THE DIAGNOSIS OF 
INTRACAVITARY ABNORMALITIES. 
68 
14 META-ANALYSIS ON THE DIAGNOSTIC 
ACCURACY OF HYSTEROSCOPY IN EVALUATION 
OF UTERINE CAVITY STRATIFIED BY DIFFERENT 
SUBGROUPS. 
70 
 
                                      LIST OF FIGURES 
S.NO LIST OF FIGURES 
PAGE 
NO. 
1 FIGO CLASSIFICATION SYSTEM FOR CAUSES OF 
AUB IN NONGRAVID REPRODUCTIVE AGE GROUP 
WOMEN. 
6 
2  HYSTEROSCOPE 42 
3  THE DISTRIBUTION OF GRAVIDOUS WOMEN IN OUR 
STUDY 
44 
4  AGE DISTRIBUTION OF PATIENTS WITH ABNORMAL 
UTERINE BLEEDING. 
45 
5  AGE DISTRIBUTION WITH REGARD TO 
COMPLAINTS 
47 
6 DURATION OF PATIENTS SYMPTOMS. 48 
7  HYSTEROSCOPIC DIAGNOSIS IN OUR PATIENTS. 50 
8  HYSTEROSCOPIC FINDINGS IN OUR PATIENTS 51 
9  HISTOPATHOLOGICAL FINDINGS IN OUR PATIENTS 55 
10 HYSTEROSCOPIC  FINDING 
a. PROLIFERATIVE ENDOMETRIUM  
b. SECRETORY ENDOMETRIUM 
c. SUBMUCOUS MYOMA 
d. ATROPHIC ENDOMETRIUM  
e. HYPERPLASTIC ENDOMETRIUM   
 
11  PROLIFERATIVE AND SECRETORY ENDOMETRIUM  
12  SIMPLE AND COMPLEX HYPERPLASIA   
13 LEIOMYOMA UTERUS AND ATROPHIC 
ENDOMETRIUM 
 
 
1 
 
INTRODUCTION 
 
 Abnormal uterine bleeding is defined as any type of bleeding in 
which the duration, frequency or amount is excessive for an individual 
patient. One third of gynaecological consultation is due to Abnormal 
uterine bleeding (AUB). It is responsible for almost two-thirds of 
hysterectomies. 1-5,8-10 The prevalence of abnormal uterine bleeding 
(AUB) is estimated to be 11-13% in the general population. AUB affects 
10-30% of reproductive age group women and upto 50% of women in 
perimenopausal age group.49 Incidence varies with age and reproductive 
status of the women. Incidence increases with age, reaching 24% in those 
aged 36-40 years. 48 Endometrial sampling is considered essential in AUB 
to confirm the bening nature of the disease and excluding malignancy by 
histopathological examination. This is important to decide the treatment 
modality. 
  The problem is that uterine bleeding has a wide range of 
diagnostic possibilities and confusion is generated when review and 
reports fail to outline the diagnostic evaluation of the patient who 
presents with abnormal uterine bleeding. In normal to 12 week size 
uterus, the cause of abnormal bleeding often remains obscure. 49 Goals of 
clinical management are primarily dependent upon attaining a correct 
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etiological diagnosis. The history, physical examination and pelvic 
examination attempt to determine the site of the bleeding and its source. 8, 
9,10 Information gathered from this will suggest what direction the 
investigation would take and the treatment modality. 9-13 
 Traditionally Ultrasonography and Dilatation and Curettage 
were the most common investigations employed in the evaluation of the 
causes of abnormal uterine bleeding. Ultrasonography clearly depicts the 
uterine contour, any lesion in the myometrium like fibroid and the status 
of the ovary, but fails to provide adequate information regarding the 
endometrium. The endometrial pathology like small submucous fibroid, 
endometrial hyperplasia is missed sometimes by ultrasound. Dilatation 
and Curettage is a blind procedure done without knowing the exact 
location of the lesion or the pathology of the endometrium and the 
endometrium has to be sent to the pathologist to study histological 
patterns and for the report. 
 Hysteroscopy has ushered a new era in the evaluation of 
abnormal uterine bleeding.1-10 By direct visualization of the uterine cavity 
it is able to pin point the etiology in majority of the cases. It can 
accurately detect endometrial hyperplasia and aids in the early diagnosis 
of endometrial carcinoma and uterine polyps.  The judicious use of 
hysteroscopy to manage this medical entity adds a new dimension in 
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handling this often perplexing problem. This study has been taken up to 
analyze the role of hysteroscopy in the evaluation of Abnormal Uterine 
Bleeding in terms of accuracy of hysteroscopic findings and contribution 
of the procedure to clinical diagnosis. It also aims to correlate 
hysteroscopic findings with histopathological results. The patients 
included are in the reproductive age group. 
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AIM AND OBJECTIVE 
 
1. To identify the cause of abnormal uterine bleeding in patients with 
AUB. 
2. To identify any endometrial lesions like polyp or fibroid.  
3. To evaluate the endometrial surface for the presence of 
hyperplasia. 
4. To obtain endometrial curretings for histopathological evaluation 
and its correlation with the hysteroscopic findings. 
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REVIEW OF LITERATURE 
 
 Abnormal uterine bleeding occurs in 10-30% of the reproductive 
age group women 49 and is one of the most common gynaecological 
complaints. Abnormal uterine bleeding is the direct cause of a significant 
health care burden for women, their families, and society as a whole. 
There is no standard nomenclature or etiological classification or 
standardized methods of investigation for AUB among non gravid 
women of reproductive age group. 50 These deficiencies hamper the 
ability of investigators to study homogenous populations of patients 
experiencing AUB, and make it difficult to compare studies performed by 
different investigators or research groups. The investigative leverage 
provided by meta-analysis is undermined and, in some instances, made 
counterproductive because inaccurate conclusions may result. Hence a 
universally accepted system of nomenclature and classification has been 
developed by the FIGO. 50 The development of such a system is made 
somewhat more complex by the fact that a variety of potential causes may 
coexist in a given individual and because many definable entities that 
often contribute to, or cause AUB are frequently asymptomatic. The 
classification system proposed by FIGO is as follows, 
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Figure.1 FIGO classification system of causes of AUB in nongravid 
reproductive age group women. 
 Although uterine bleeding is a normal physiologic episode occurrence 
for most women, its characteristics neverthless vary considerably. The 
problem is that uterine bleeding has a wide range of diagnostic 
possibilities and confusion is generated when review and reports fail to 
outline the diagnostic evaluation of the patient who presents with 
abnormal uterine bleeding patterns. Goals of clinical management are 
primarily dependent upon attaining a correct etiological diagnosis. The 
history, physical and pelvic examination attempt to determine the site of 
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the bleeding and its source. Information gathered from this will suggest 
what direction the investigation would take.52 
 
The various causes of AUB can be broadly classified into the 
following three categories: 
1. Organic lesions. 
2. Dysfunctional uterine bleeding and 
3. Systemic diseases. 
 
ORGANIC LESIONS CAUSING AUB: 
 It occurs mainly due to the structural lesions or pregnancy 
associated causes. Structural causes are further divided into focal and 
diffuse. Focal causes include fibroid, endometrial polyp, adenomyosis. 
The diffuse lesions are atrophic endometrium, endometrial hyperplasia, 
endometrial carcinoma and diffuse adenomyosis. 20%-40% of patients 
with AUB are diagnosed to have fibroid uterus. 53 
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Table.1 Structural causes of AUB 
Focal lesions of endometrium Polyp, leiomyoma, focal 
adenomyoma 
Diffuse lesions of endometrium Endometrial hyperplasia, 
endometrial carcinoma, diffuse 
adenomyosis 
Mechanical causes Intrauterine contraceptive devices 
Infections  Endometritis, PID, tuberculosis 
Vascular  Arterio-venous malformations 
Partial outflow obstruction Asherman’s syndrome 
      
Dysfunctional uterine bleeding: 
 It includes ovulatory and anovulatory DUB. Commonest is 
anovulatory and it occurs in extremes of reproductive age group. It is due 
to immaturity of the hypo-thalamo pituitary axis in puberty and due to 
insensitive ovarian follicles in the perimenopausal women.  
 
 Dysfunctional uterine bleeding was considered a diagnosis of 
exclusion after eliminating the causes of AUB. 51 But in women of 
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reproductive age group it has been classified by FIGO as AUB-N (not yet 
classified) 
 
Table.2 Causes of AUB in Reproductive age group women 49 
Pregnancy associated causes 
Anovulatory causes 
Coagulation disorders 
Fibroid uterus-submucuos, intramural 
Endometrial polyps 
Endometrial hyperplasia, endometrial carcinoma 
Infectious causes and medication related 
Complications of intra uterine contraceptive device. 
 
Endometrial carcinoma: 
 The incidence of endometrial carcinoma increases with age. The 
incidence is 2.3 per 1, 00,000 between 30-39 years and it increases to 
36.2 per 1, 00,000 between 40-49 years. 54 
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Table.3 Causes of AUB in perimenopausal women49 
Anovulation associated Hypo-thalamo pituitary dysfunction 
Focal uterine lesions Fibroids, polyps, adenomyosis 
Diffuse uterine lesions Diffuse adenomyosis, endometrial 
hyperplasia and carcinoma 
 
Endometrial hyperplasia: 
  Physiological or pathological alterations of the endometrial 
glands and stroma produced by hyperestrogenic state or carcinoma 
endometrium or hormonal therapy. The risk of hyperplasia progressing to 
carcinoma depends on the various grades of cytological atypia. It is also 
influenced by age, obesity, underlying ovarian disease, endocrinopathy 
and exogenous hormone exposure. 57,58  Endometrial hyperplasia may 
produce obvious space occupying lesions in which diagnosis is easy with 
hysteroscopy, but it may not be very obvious especially in early stages of 
the disease. Exact pathology is diagnosed by histopathological 
examination. 
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Table.4 Classification of endometrial hyperplasia 59 
Type of hyperplasia Progression to cancer(%) 
Simple (cystic without atypia) 1 
Complex(adenomatous without atypia) 3 
Simple (cystic with atypia) 8 
Complex(adenomatous with atypia) 29 
  
Uterine polyps: 
 Polyps are easily missed by D&C and hysteroscopy is the most 
reliable method for its diagnosis. Endometrial polyps secondary to 
treatment with Tamoxifen for breast cancer patients is a major problem 
for which hysteroscopy is highly valuable. Taponeco and colleagues 
studied 414 patients with breast cancer. All of them underwent 
hysteroscopy. Out of that 334 were treated with Tamoxifen for breast 
cancer and 80 controls. Significant difference was found in malignant 
(7.8%) and atypical (9%) hyperplastic polypi between the treated and 
control group. So the authors concluded that hysteroscopy and biopsy 
should be taken in any women receiving Tamoxifen and presenting with 
AUB. 56 
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Leiomyomas: 
 Leiomyomas of the uterus are the most common intrauterine 
masses. These are the most common intrauterine bening neoplasms. If 
hysterectomy specimens are studied, around 75% had histologic evidence 
of leiomyoma. These are found in black women than white race. Myomas 
are usually seen in 30-40 years of age. 
 Many women experiencing abnormal uterine bleeding is due to 
myoma, thus affecting reproductive performance. Submucous myomas 
are more common in causing abnormal uterine bleeding. Also these 
submucous myomas cause recurrent pregnancy loss, even infertility and 
impedes conception due to mechanical hindrance. Large myomas cause 
preterm labour, pressure symptoms, obstruction of labour, postpartum 
haemorrhage, inversion of uterus and subinvolution of uterus. It also 
causes secondary haemorrhage. 
Atrophic Endometrium: 
 Postmenopausal AUB is mostly caused by atrophic 
endometrium. Type II endometrial carcinoma may arise in a background 
of atrophic endometrium and are estrogen-independent. 55 
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DIAGNOSTIC PROCEDURES: 
 The commonly used diagnostic procedures for AUB are 
reviewed.    
Dilatation and curettage: 
  Traditionally Dilatation and Curettage is the most common 
investigations employed in the evaluation of the causes of abnormal 
uterine bleeding. Dilatation and Curettage is a blind procedure and half of 
the endometrial cavity is missed during D&C. Perforation can occur 
during the procedure and if suspected the procedure should be with held 
and observe for any bleeding or sings of intestinal injury and infection. 
Ultrasonography: 
  Ultrasonography clearly depicts the uterine contour and the 
status of the ovary, but fails to provide adequate information regarding 
the endometrium. Endometrial hyperplasia and carcinoma can be 
screened using transvaginal ultrasound (TVS). Measurement of 
endometrial thickness (ET) is not useful in premenopausal women for 
distinction between carcinoma and hyperplasia. Persistent non cyclical 
bleeding with ET> 11mm should arouse the suspicion of endometrial 
carcinoma. 60 TVS detects focal lesions causing AUB but may not be that 
useful for hyperplasia in premenopausal women. 
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Saline infusion sonography: 
 SIS is a method which improves the visualization of endometrial 
cavity during TVS. A pelvic examination is done and a bivalve speculum 
os placed. Cervical preparation is done with an anti-septic solution and a 
small catheter is introduced into the cervical os for insertion of sterile 
saline. Speculum is then removed and saline infused into the uterine 
cavity during TVS. Dueholm and colleagues compared the accuracy of 
SIS with TVS, hysteroscopy and MRI. They concluded that SIS had an 
overall sensitivity comparable to the gold standard of hysteroscopy. SIS 
is less invasive than hysteroscopy. 56 Compared to TVS it is more 
invasive and expensive and more expertise needed for the procedure. 
Hysterosalpingogram: 
 An X-ray based contrast test to evaluate the uterine cavity and 
the fallopian tubes. 56 Hysterosalpingogram is one of the important 
investigation in the diagnosis of uterine pathology. The disadvantage of it 
is that cannot show the exact nature of the intrauterine lesion. 56 and 
cannot be used for the treatment unlike hysteroscopy. It is only a 
diagnostic modality. Even then HSG remains a useful investigation in 
evaluating the uterine and tubal pathology mainly in infertility.  
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Hysteroscopy: 
 Hysteroscopic procedures were first described by Panteleoni in 
1869, but until 1970s this technique was not shown interest. In 1980s, 
hysteroscopy replaced the blind D&C procedure. 56 Hysteroscopy has 
ushered a new era in the evaluation of abnormal uterine bleeding. By 
direct visualization of the uterine cavity it is able to pin point the etiology 
in majority of the cases. It can accurately detect endometrial hyperplasia 
and aids in the early diagnosis of endometrial carcinoma and uterine 
polyps. 2 However, if office hysteroscopy is available, there may be 
additional value in endometrial polyps, because they could be removed in 
the same setting. 50 The judicious use of hysteroscopy to manage this 
medical entity adds a new dimension in handling this often perplexing 
problem. In this method, the whole uterine cavity is directly observed 
through hysteroscope. In case of any pathological lesion, biopsy is taken 
and treatment is carried out through hysteroscopy if needed (e.g. removal 
of submucosal myoma or endometrial polyp). This procedure has been 
generally accepted as the gold standard for evaluation of the uterine 
cavity. The most important benefit of hysteroscopy is its "see and treat" 
potential, which not only avoids multiple hospital visits, but also provides 
higher patient satisfaction. However to get the maximum benefit from 
this procedure, it is important to select patients properly and the 
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investigation should be performed by skilled personnel to obtain optimal 
results so that patients are managed adequately and cost effectively. 
General anesthesia is not necessary for diagnostic hysteroscopy, since the 
procedure can be performed by paracervical block or venous 
tranquilizers. This is why it is counted as an appropriate outpatient 
method, economizing patient’s time and money. The patients who have 
contraindications for general anesthesia also benefit from this procedure. 
 Due to its high accuracy and patient acceptance, outpatient 
diagnostic hysteroscopy should become a first line investigation in 
patients with AUB. 1-8,17,18,19 With high sensitivity and specificity of this 
method in diagnosis of uterine lesions, it can be used as an ideal 
diagnostic tool to assess the patients with AUB.  
Indications of hysteroscopy: 
1.  Abnormal uterine bleeding 
2.   Menorrhagia 
3.  Postmenopausal bleeding 
4.  Intrauterine masses-leiomyoma 
5.   Asherman’s syndrome 
6.   Missed IUCD. 
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7.   Foreign body. 
8.   Abnormal hysterosonogram  
9.   Before artificial reproductive therapy 
Proliferative endometrium: 
 In hysterosocpic examination the early proliferative 
endometrium appears with comma shaped coiled arteries budding in a 
perpendicular direction from the basal arteries. 68 These basal arteries lies 
on the surface of the endometrium and are parallel to one another. 64-67 In 
late proliferative phase the rapidly growing endometrium attains 7-8mm 
and the vessels are highly convoluted and spiral like. 11 The coiled 
arteries are seen prominently. 
Secretory endometrium: 
 In hysteroscopy the early secretory endometrium appears as  
double layered. The characteristic feature is the end arterioles of the 
coiled arteries surround the glandular openings in the superficial layer of 
the endometrium.the superficial layer is transparent and the deep layer 
containing the coiled arteries is seen through this transparent layer. 64 In 
late secretory phase the colour changes from pink to ivory. A number of 
changes like stromal edema, accumulation of secretions are seen. 70,71 The 
interglandular stroma becomes dense and the coiled arteries are no longer 
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visible. Glandular openings surrounded by the terminal arteries remain 
visible.  
Intrauterine masses: 
 Intrauterine masses like endometrial polyps which is diagnosed 
by ultrasound can be confirmed by HSG or by SIS. But definitive 
diagnosis is made by hysteroscopy. It visualizes the polyp, its size, site of 
origin, and also for the trearment of the endometrial polyp. Also it 
evaluates the pathophysiological characteristics of the polyp and focal 
hyperplastic growth of the basalis layer. Incidence of polyp in general 
population is 2-4%. 1-7 Mainly in cases of infertility it is one of the main 
cause. It acts an intrauterine mass hindering the implantation and 
mechanical hinderance. Also these cause abnormal uterine bleeding. 
Submucous myoma: 
 The definitive diagnosis of submucous myoma is by 
hysteroscopy. They are seen as white hemispherical masses and are 
covered by thin walled fragile vessels and endometrium. They can be 
sessile or pedunculated. If the tumour is less than 2 cm in size it is easy to 
remove through the hysteroscopic route. 41-44 And if it is a pedunculated 
large submucous myoma it can be resected. If bleeding is anticipated it is 
good to treat with GnRH analogues prior to surgery. This reduces the 
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blood loss during surgery by causing shrinkage of the tumour.  Maximal 
shrinkage occurs after 3 months of therapy. 
Endometrial hyperplasia: 
 In younger women, endometrial hyperplasia and anatomical 
abnormalities, such as uterine fibroids, comprises the main pathology. 
The recommendation regarding investigation of abnormal uterine 
bleeding from the Royal College of Obstetricians and Gynaecologist is 
that women over the age of 45, should be investigated with hysteroscopy 
and endometrial biopsy. Outpatient hysteroscopy is both feasible and 
highly acceptable in the majority of patients, giving a high detection rate 
for intrauterine pathology. It is more sensitive and specific than 
transvaginal ultrasound or blind endometrial sampling. 4 The advantages 
of hysteroscopy as an accurate diagnostic tool are that it allows direct 
visual observation and localization of the pathology and targeted biopsy. 
It allows correct diagnosis to be made, reduces the need for major and 
unnecessary surgery, and is therapeutic in most of the patients with 
endometrial hyperplasia. 
Endometrial carcinoma: 
 In case of endometrial carcinoma positive hysteroscopic findings 
are highly predictive of cancer but must always be confirmed by directed 
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biopsy. 9 A negative hysteroscopic examination may miss endometrial 
carcinoma. Random biopsies via hysteroscope should be performed in 
these women. 10  
Contraindications: 
 Absolute contraindications for hysteroscopy are cervical 
carcinoma, acute pelvic infection and pregnancy. If there is pelvic 
inflammatory disease with an unretrievable IUD, first treat the pelvic 
infection with antibiotics and then do an office hysteroscopy after the 
infection settles. Relative contraindications include large size myomas 
and associated medical disorders. 
Equipment: 
 The mechanism by which hysteroscopy works is through optical 
and thermal energy. Uterine cavity is a distensible space and it can be 
distended with a medium for visualization of the cavity. 20,21,23,30,39 The 
scope is introduced through the cervix and the inner aspect of the uterus, 
endometrial lining, cornua are all visualized. 
Distension medium: 
 For routine outpatient hysteroscopy, the choice of distension 
medium between carbon dioxide (CO2) and normal saline should be left 
to the discretion of the operator as neither is superior in reducing pain, 
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although uterine distension with normal saline appears to reduce the 
incidence of vasovagal episodes. 50 
 Uterine distension with normal saline allows improved image 
quality and allows outpatient diagnostic hysteroscopy to be completed 
more quickly compared with carbon dioxide. Operative outpatient 
hysteroscopy, using bipolar electrosurgery, requires the use of normal 
saline to act as both the distension and conducting medium.  11 
Distension medium is classified as gaseous and fluid medium. 
Carbondioxide: 
 It has been extensively used in distending the uterine cavity. It is 
inexpensive, low flow rates needed and easy to maintain. Visualization 
using CO2 was good and adequate distension is produced. CO2 is rapidly 
absorbed through blood stream and rapidly cleared through the lungs. 
Disadvantage of CO2 is that it often leaks out around the hysteroscope. 
CO2 gets mixes with blood and forms bubbles. When laproscopic 
insufflaters are used, they have high flow rates and have caused death due 
to CO2 embolism. 
Fluid distension medium: 
 Fliud distension medium includes high-molecular weight dextran 
(hyskon), electrolyte solutions and non-ionic solutions (sorbitol, 
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mannitol, glycine). Hyskon is rarely used for many reasons. It is in a 
consistency of syrup and messy to use. If not cleaned properly it results in 
immobilization of moving parts. Even with bleeding visualization of the 
uterine cavity is good.  It is delivered through a 50 cc syringe and 
intravenous extension tubing. The amount of hyskon used is not more 
than 500 ml. If more than that is used it can cause pulmonary edema. 
Sometimes it also leads to anaphylaxis and disseminated intravascular 
coagulation. Overall now hyskon is not useful in hysteroscopy as a 
distending medium. 21,23 
 Low viscosity fluids are easier to use when hysteroscopy is done 
as an out patient procedure. The low density fluids include ionic fluids 
like normal saline or lactated ringer’s solution and non-ionic solution like 
sorbitol,mannitol, or glycine. The main advantage of electrolyte 
containing solutions like normal saline is their less absorption, even when 
large quantity is used and has little risk. But these solutions cannot be 
used when monopolar cautery is used. The advantage of non ionic 
solutions is that they can be used with monopolar cautery but if large 
amounts are used it can cause water intoxication if there is more 
absoption. 
 The fluid used for distension should be under measurement and 
accurate measurements of fluid absorption to be maintained through the 
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procedure. Usually diagnostic hysteroscopy is done as an out patient 
procedure in short duration and there is no risk of water intoxication. 
Therapeutic hysteroscopy is usually done in surgical centres. The 
endometrial cavity is usually visualized under continuous flow of 
distension medium.  The hysteroscope has two channels. Through the 
inflow channel the distension medium is allowed to flow in and there is 
an outflow channel through which the fluid comes out. In operating 
hysteroscopes there is another channel through which the operating 
instruments can be passed through. 
Lights and optics: 
 The hysteroscope has a proximal eyepiece and distal objective. 
The light source is attached to the outer metallic sheath. There are inflow 
and outflow channels attached to the outer sheath. Even after the advent 
of fibreoptic hysteroscopes the visual clarity of rigid scopes remains the 
maximum till now.  Additionally the rigid systems are more stable for 
therapeutic procedures. The varities of hysteroscope are flexible, rigid, 
microhysteroscope. 
Flexible hysteroscope: 
 The advantage of flexible hysteroscope 20,21,23,30,40 is that its 
smaller diameter which causes less discomfort. Most patients do not 
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require cervical dilatation or anaesthesia. The Olympus hysterofibroscope 
provides an ergonomic design and singlehanded control. Minor surgical 
procedures can be perfomed through this hysteroscope, including directed 
biopsy or exicisional biopsy of small polyps. 
Microhysteroscope: 
 Imagyn medical has introduced the microspan hysteroscope 
system, which has an integral component of 1.6 mm sheath called 
microhysteroscope 23,40 with enhanced optical visualization. The diameter 
of the outside sheath is equal to that of the pipelle. The image fibre 
system and the micro optics of the scope provides resolution of around 
150% when compared to similar size micro hysteroscopes. The visual 
resolution of this is two to three times that of the similar size 
hysteroscope. This can be added to a microspan sheath which has an 
expandable working channel and in that channel 2mm semirigid 
instruments can be passed for biopsy or exicision. This outer sheath also 
allows the flow the distension medium. There is limiting valves to control 
the speed of the distension medium flowing into the uterine cavity. 
Rigid hysteroscope: 
 The rigid hysteroscopes 20,31,40 range from 3 to 5 mm as the 
outside diameter. It is aligned so that there is continuous flow of 
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distension medium. The visual resolution of these systems are more than 
the large resectoscopes and enables excellent visualization. Recently used 
3.2 mm scopes do not require any cervical dilatation. If needed it is given 
with a paracervical block. The operating channels allow the passage of 
semirigid instruments or bipolar electrodes. These rigid hysteroscopes are 
more useful in therapeutic procedures due to its good resolution along 
with bipolar technology. 
Procedure 
Timing of the procedure 
 Diagnostic hysteroscopy is done in mid proliferative phase of the 
cycle, where the bleeding has stopped and the growth of endometrium is 
such that it does not hinder the view. When done later secretory 
endometrium is confused with polyps. If therapeutic procedure is 
performed in office setup preoperative preparation with GNRH analogues 
provides thinning of the endometrium, allowing excellent visualisation 
and perhaps more efficacious treatment. 
NSAIDS: 
 The patient should be treated with non steroidal anti 
inflammatory drugs around 30-60 minutes before surgery. It can be either 
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taken orally or rectal suppository can be used. A mild sedation may be 
needed in some patients. 
Patient position: 
 The patient is placed in the dorsal lithotomy position and a 
digital examination is made to ensure the uterine size and position and 
adenexal details. The usually used examination table or preferably an 
adjustable electric bed is used for examination. 
Cervical preparation: 
 After introducing a bivalve speculum, the cervix is cleansed with 
povidone solution. After introducing the hysteroscope the speculum has 
to be removed. 
Paracervical block: 
 The use of paracervical block is controversial. In general with 
smaller sized hysteroscopes, no cervical dilatation and analgesia is 
required. The studies done showed no significant difference in pain 
perception scores by the patients with and without cervical block. 17-19 
Insertion of hysteroscope: 
 The alignment is checked before introducing the scope. Then it 
is gently introduced through the vagina under visualization of bivalve 
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speculum and then into the external os. The speculum is removed which 
allows more space for the manipulation of the hysteroscope. The external 
os is visualized, and then the endocervical canal is visualized. 
Insufflations medium either liquid or CO2 is injected, allowing 
visualization of the cavity, which appears as a dark spot. The location of 
this dark spot depends on the angle of the scope and position of the 
uterus. The hysteroscope is then directed towards this dark spot until the 
cavity is entered. The flow of medium is adjusted so that the cavity is 
adequately distended. Then the uterine cavity is examined systematically 
from the fundus, anterior and posterior walls, both tubal ostia, and the 
lower uterine segment. The findings should be recorded in examination 
sheet for permanent record keeping. 
 Inadequate visualization is most commonly encountered during 
hysteroscopy. The most common cause of is inadequate flow of 
distension medium. Flow is raised by either raising the level of bag or 
increasing the pressure in the insufflators and this will overcome the 
problem. If the cervical canal is narrow, it may be dilated gently before 
inserting the hysteroscope. Blood in the cavity obscuring the view can be 
overcome by increasing the flow rate of the distension medium. If blood 
continues to obscure, high molecular weight dextran can be used. This 
28 
 
medium is immisible with blood but complications are more. If CO2 is 
used it can leak and can be decreased by adjusting the tenaculm. 
Complications of hysteroscopy: 
1. Inadequate visualization due to leakage of the distending medium or 
blood clot 
2. Perforation of uterus: 
 If the hysteroscope advances easily and the cavity is still not 
visualized uterine perforation has to be suspected. Also when the 
outflowing distension medium is less than the inflowing medium suspect 
perforation. The procedure is stopped. These are usually in midline and 
require no further therapy and needs observation. If monopolar or bipolar 
cautery is used then rule out thermal injuries of bowel. These patients 
should undergo a laproscopic evaluation of the pelvis, with possible 
laprotomy if indicated. 
3. Infection : 
 Usually rare after hysteroscopy. Any cervical discharge present 
has to be evaluated before the procedure and treated with antibiotics and 
to be proceeded. In patients with valvular heart disease, intravenous 
antibiotics are given before the procedure. 
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4.Bleeding: 
 Usually rare after hysteroscopy especially when done as a 
diagnostic procedure. As more and more therapeutic procedure is 
performed using hysteroscopy this complication is now increasing. 
Bleeding can occur from the cervix or the urterine cavity. The cervix 
should be carefully inspected for any injury and bleeding at the 
tenaculum holded site. Intracavitary bleeding due to resection of septum 
or fibroids or after ablation of endometrium may be controlled by placing 
a Foley’s catheter  with 30cc balloon inflated. It acts both as a tamponade 
and also as a drain. It has to be kept for about 24 hours. Antibiotics to be 
given for these patients. 
5. Economic considerations: 
 After recognizing the benefits of hysteroscopy from both a 
diagnostic and therapeutic viewpoint, the treating physician should decide 
in which setting to perform the procedure. One should recognize that state 
of the art system is expensive as it includes light sources, video 
equipment and other hysteroscopic equipments. Additional cost may 
include if bipoloar cautery is used. 
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Review of Diagnostic strategies: 
 Zhu HL et al, 2010 in his study found the utility of hysteroscopy 
and directed biopsy in the diagnosis of endometrial carcinoma in 287 
patients who were treated in Beijing University People's Hospital, 
Beijing. The study showed that when compared with fractional D&C, 
hysteroscopy and directed biopsy had diagnostic accuracy before surgery 
and also found out the cervical involvement more precisely in 
endometrial carcinoma patients, but it did not increase the positive 
peritoneal cytology rate or affect the prognosis of these patients. 
 Patil SG et al, 2009 in his prospective study, did diagnostic 
hysteroscopy in AUB cases and found that hysteroscopy provides more 
accurate diagnosis than dilatation and curettage. 
 Ricardo Bassil Lasmar et al, 2008 in his retrospective study, 
showed the correlation of hysteroscopy with histopathological analysis. 
Most frequent histologic diagnosis is normal endometrium in controls but 
found to be endometrial polyps in hysteroscopic findings in patients with 
AUB. 
 Bender R, Rzepka-Gorska I, 2007  in his study compared 
hysteroscopy directed biopsy and dilatation and currettage in 
perimenopausal women and found that hysteroscopy directed biopsy is 
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better than dilatation and curettage in disclosing all types of intrauterine 
lesions. 
 Van dongen H, 2006 in his study done a Meta analysis of 
diagnostic hysteroscopy in AUB and found that positive and negative 
likelihood ratio were 7.9% and 0.04% and overall success rate was 96.9% 
 L. Birinyi et al, 2004  in his study  have performed hysteroscopy 
in  835 patients with biopsies over more than 13 years and compared the 
hysteroscopic findings with histological findings. They found that the 
sensitivity of hysteroscopy was 0.52 for hyperplasia, 0.87 for polyps, 0.85 
for myomas, 0.68 for carcinoma, and 0.73 for atrophy. 
 Gianninoto A et al, 2003, in his study did hysteroscopy in 512 
patients in the age group of 38-80 years with AUB from January 1996 to 
December 2001. It was observed that hysteroscopy is simple, safe, well 
tolerated and reliable in the diagnosis of AUB among all age groups and 
it can drastically reduce the need for conventional curettage, thereby 
increasing patient satisfaction and lowering costs. 
 Pasqualotto EB et al, 2000, in his study did hysteroscopy in 375 
patients with AUB. It was seen that diagnostic hysteroscopy is a safe 
outpatient procedure and is associated with high satisfaction in carefully 
selected patients. He showed that hysteroscopy is a better diagnostic test 
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for intracavitary abnormalities of uterus than TVS and endometrial 
biopsy by dilatation and curettage.  
 The value of the diagnostic test for abnormal uterine bleeding is 
provided in many comparative studies between ultrasound, 
sonohysterography and diagnostic hysteroscopy, all these correlated with 
biopsy. The quality of these studies is affected by the lack of common 
spectrum for the patients under study. But this should be overcome by the 
recognition that the reference test was invasive. 
 All the diagnostic tests mentioned had likehood ratios similar in 
the non-diseased. But considerable variation was seen between 
transvaginal ultrasound and sonohysterography and showed that pooling 
of likelihood ratios was not satisfied. But this has been overcome by 
diagnostic hysteroscopy. This test did not have much heterogenicity. 
 The results found out of these studies were detection of any 
intrauterine pathology. Fibroids especially submucous, endometrial 
hyperplasia and endometrial carcinoma. Transvaginal ultrasound is more 
specific in diagnosing intrauterine pathology but lacks sensitivity. 
Specificity is 95% but sensitivity is only 60 to 77%. For submucous 
myomas it has a sensitivity of 80% and specificity of 69%. Many 
intramural myomas are diagnosed as submucous by TVS. 
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 Transvaginal ultrasound has a high false negative rate in 
diagnosing intrauterine pathology when compared to diagnostic 
hysteroscopy. SIS and hysteroscopy are equally accurate in diagnosing 
submucous myomas and the likelihood ratios of both lies in a good range 
suggesting that both are equally good tests. Both hysteroscopy and SIS 
are accurate in diagnosing endometrial hyperplasia. 
 Considering various studies, combination of TVS followed by 
SHG is better than TVS alone for intrauterine abnormalities. But no 
studies combined both these two tests. Also reviewing the studies showed 
that transvaginal ultrasound is more sensitive in diagnosing endometrial 
hyperplasia in women of reproductive age group if the endometrial 
thickness is more than or equal to 12mm. 
 It was Siegler in 1976 who published an article which included 
257 patients. All of them underwent hysteroscopy as a diagnostic test for 
abnormal uterine bleeding under general anaesthesia. After this study, 
hysteroscopy has become one of the first line tests in diagnosing 
endometrial pathology. It can be done as an office procedure with 
minimal analgesia. 
  It is one of the continual modifications of endoscope which is 
used for imaging human inner cavities. Main disadvantage of 
hysteroscopy is its invasiveness and discomfort. Remarkable changes 
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have been made in the field of hysteroscope since its invention. Many 
advances in this technique have decreased the caliber of the hysteroscope 
which decreases the discomfort and pain associated with this procedure. 
Some authors have said that the accuracy of diagnosis based on 
hysteroscopic visualization is high for endometrial cancer and moderate 
for other endometrial diseases. Since Hysteroscopy and its directed 
biopsy is more accurate than dilatation and curettage, it is considered an 
accurate ‘gold standard’ in uterine cavity evaluation. 7 
 Hysteroscopy is better and useful diagnostic tool for assessing 
intracavitary abnormalities. 5 It  is safe with less significant complications 
and it allows for the visualization of the probable uterine source of 
bleeding in the presence of organic lesions and also provides a means to 
sample the site most likely to yield positive results(4). Hence 
Hysteroscopic evaluation in patients with abnormal uterine bleeding is 
needed. 
 There was considerable relation seen in association with the age 
of the patient and the histopathological findings. 25 It was observed that 
submucous myomas were commonly seen in pre-menopausal women, 
whereas endometrial polyp is seen with increasing age. Inspite of the fact 
that SHG did not revealed any endometrial pathology in many young 
patients with AUB, it was detected by hysteroscope. This was especially 
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significant in female patients with infertility, where hysteroscopy is one 
of the important investigations for infertility. 23,24,27 
 Many endometrial lesions that caused infertility included 
endometrial polyps, endometrial hyperplasia, intrauterine adhesions, and 
especially submucous myomas. 15,17,19 Many of these lesions caused 
abnormal uterine bleeding along with infertility. Hysteroscopy is very 
much useful in diagnosis of these lesions, especially endometrial polyp 
and endometrial hyperplasia, were hysteroscope is both diagnostic and 
therapeutic. Endometrial polyp can be removed under vision and 
hyperplastic endometrium can be ablated.  Endometrial ablation can be 
done under hysteroscopic guidance under vision. Hysteroscopy is also 
useful in evaluation of postmenopausal bleeding. Biopsy can be taken 
under hysteroscopic guidance if any suspisicious lesion is found and is 
more sensitive. A study by Gimpelson and Rappold was done to 
quantitate the lack of diagnostic precision of dilation and curettage in 
finding out intrauterine pathology when compared to hysteroscope in 
patients with abnormal uterine bleeding.  22 The hysterocopic correlation 
with intrauterine pathologic findings was statistically significant 
(p<0.001) 
 The sensitivity of dilatation and curettage versus hysteroscopic 
biopsy in endometrial hyperplasia was 65% and 98% respectively 
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(Loeffer). Endometrial hyperplasia was suggested with office 
hysteroscopy in 21.2% of patients enrolled in a study. In these 50 patients 
histological examination confirmed the diagnosis of endometrial 
hyperplasia, with a 71.4% positive predictive value (PPV) of the 
technique. In 33 cases focal lesions was seen. 41 In 37 cases hysteroscopy 
suggested a diffuse hyperplasia and the PPV in this is 71.6%. Overall 
hysteroscopy proved a sensitivity of 80.6% and a specificity of 92.5% 
compared to histology, in the diagnosis of endometrial hyperplasia. 42,43  
Hysteroscopy along with other modalities like HSG and USG augments 
the final diagnosis but does not replace HSG. The advantage in 
hysteroscopy is its direct visualization of the intrauterine cavity, which 
the other investigations do not have. Also the disadvantage of 
hysteroscopy is that it is not useful in pathology of myometrium and 
subserous myoma which is also associated with abnormal uterine 
bleeding. 
 The previously used 5mm hysteroscopes caused much 
discomfort and pain which needed anaesthesia and the procedure done in 
operative theatre settings. Recently used 3.2 mm scopes cause minimum 
discomfort and reduced the need of analgesia. There was no need for 
cervical dilatation when 3.2mm scope was used. Cervical dilatation 
depends also on the parity, and easily passed in multiparous women. For 
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these patients intracervical or paracervical anaesthesia was effective. A 
study by Kremer et al showed that 93.3% of patients tolerated 
hysteroscopy well. Only 5.4% patients experienced moderate to severe 
pain. In patients where hysteroscopy failure seen had difficulty in 
insertion in 47% and poor visibility in 42%. An alternative for this is 
flexible hysteroscopy. But the disadvantage of flexible hysteroscope is a 
little poor quality of visualization when compared to rigid hysteroscope. 
Advantage of flexible hysteroscope is that it causes less discomfort and 
no need of anaesthesia. 
 The main purpose of this study was to determine the diagnostic 
value of hysteroscopy in evaluating the uterine cavity in order to improve 
the accuracy in investigating patients with abnormal uterine bleeding. By 
reviewing the above studies it is clear that diagnostic hysteroscopy should 
be considered the firstline investigation for evaluation of AUB. The 
disadvantage of in the diagnosis of myometrial and adenexal lesions can 
be overcome by subjecting the patients to ultrasound before the procedure 
and followed by hysteroscopy. 
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MATERIALS AND METHODS 
 
 This is a prospective study in the role of diagnostic hysteroscopy 
in evaluation of AUB in reproductive age group women and its 
histopathological correlation. This study has been conducted in the 
Department of Obstetrics and Gynaecology, Coimbatore Medical College 
Hospital. The duration of the study was from December 2012 to 
November 2013. Clinical assessment and thorough local and systemic 
examination of 50 patients of reproductive age group was done and 
relevant findings were recorded with informed consent. 
Pre operative investigations: 
• Haemoglobin 
• Platelet count 
• White cell count 
• Blood sugar 
• Blood urea 
• Serum creatinine 
• Blood grouping 
• Rh typing 
• HIV 
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• VIA/VILI/ Colposcopy 
• ECG 
• Chest X-ray 
• Ultrasound abdomen 
 
Aneasthetic fitness was obtained. 
Injection TT ½ cc given intramuscularly. 
Prophylactic antibiotics with second generation cephalosporins was given 
in pre operative and post operative period. 
STANDARD INDICATIONS: 
 In this study hysteroscopy was done to evaluate abnormal uterine 
bleeding in reproductive age group women. And also patients with 
infertility and AUB, suspected fibroid with bleeding are included in the 
study.  
Premenopausal women with 
• Menorrhagia 
• Metrorrhagia 
• Polymenorrhea. 
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EXCLUSION CRITERIA: 
 
1. Puberty menorrhagia 
2. Severe anaemia 
3. Pelvic infection 
4. Surgical and medical complications like uncontrolled 
diabetes, severe hypertension and bronchial asthma. 
5.  Cervical carcinoma. 
HYSTEROSCOPIC PROCEDURE: 
 Hysteroscopy was done in the proliferative phase of the 
cycle.The procedure was done with aministration of short intravenous 
anaesthesia. In a few cases paracervial block was used. Patient’s bladder 
was emptied before the procedure. Patient was put in dorsal lithotomy 
position and perineum and vagina are gently swabbed with povidone 
iodine. Bimanual examination of pelvis was done. Sim’s bivalve 
speculum introduced into the vagina gently and the posterior vaginal wall 
retracted backwards. The anterior lip of cervix comes to view and is 
holded with the valsellam. The hysteroscope is checked before 
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introducing for the eye-piece, objective lens, clarity and then introduced 
through the vagina, ectocervix and the endocervical canal. Any lesion 
found noted. The speculum removed. None of the patient needed cervical 
os dilation during the procedure. 400 micrograms of misoprostol tablet 
was kept vaginally 6 hours before the procedure.  
 The hysteroscope used was a 30 degree hysteroscope of diameter 
4.3 mm outer sheath. Illumination of the scope was provided by a high 
intensity cold light source via a fibre optic cable and the procedure 
monitored through the video monitor. 
 Then the hysteroscope was introduced into the uterine cavity. 
Normal saline was used as the distension medium. The uterine cavity is 
allowed to get distended. Flow rates of the normal saline were around 70 
ml/min. The uterine cavity was examined in a systematic manner. The 
hysteroscope was guided through the endocervical canal into the uterine 
cavity under vision. The ostia of the tubes examined. Then the 
endometrial surface was examined. All the surfaces of uterine cavity, that 
is the anterior wall, posterior wall, and lateral walls were examined. The 
appearance of the endometrium, colour, any polyps, fibroid, hyperplasia 
and vascularity noted. During withdrawing the hysteroscope cervical 
canal visualized. 
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 Endometrial sampling was done and sent for histopathological 
examination. The examination was considered complete when all the 
parts were visualized. If any difficulty in visualization due to blood clot 
occurs then the procedure is considered as incomplete and failed. The 
hysteroscopic findings correlated with the histopathology results. 
 
Figure.1 showing the hysteroscope 
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RESULTS AND OBSERVATION 
 50 patients of reproductive age group with AUB were selected 
for the study. The duration of prospective study was between December 
2012 and November 2013. All the patients with AUB were subjected to 
hysteroscopy and biopsy and histopathological confirmation obtained for 
all. All the patients were of low socio economic status.  Hysteroscopy 
was done under intravenous sedation. It was successful in 100% of cases 
and concluded satisfactory in almost all cases. There was no failure in 
any of the patients taken for study. During and after the procedure there 
was no complication. Menorrhagia was the most common complaint in 
our study which was seen in 42 patients(84 %) of reproductive age group 
women. 6 patients(12%) presented with polymenorrhoea. 2 patients(4%) 
presented with intermenstrual bleeding.  
Table.5 showing complaints of patients in our study 
Symptom No. of patients 
Menorrhagia  42(84%) 
Polymenorrhoea  6(12%) 
Intermenstrual bleeding  2(4%) 
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Table 7 –Age distribution of patients with abnormal 
uterine bleeding 
Category 20-29 30-39 40-49 >50 Total 
Menorrhagia 4 20 16 2 42 
(84%) 
Intermenstrual 
bleeding 
1 1 0 0 2 
(4%) 
Polymenorrhoea 0 2 4 0 6 
(12%) 
 
Menorrhagia  was  found in  4 patients (8%)  in 20 – 22 years  age  
group.  20 patients (40%) were in  30 -39 years age group. 16 patients  
(32%)  were  in  42 - 49 years  age  group.   2 patients (4%) were  greater 
than 50 yaers. 
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 Table .9 showing hysteroscopic findings. 
Parity  nulliparous Multiparous 
Finding No. % No. % 
Proliferative endometrium 4 8 14 28 
Secretory endometrium 0 0 8 16 
Atrophic endometrium 0 0 4 8 
Myoma 1 2 9 18 
Hyperplastic endometrium 1 2 9 18 
Carcinoma endometrium 0 0 0 0 
  
 6 (12%) of the patients in the study included are nulliparous. 
Even in those patients no cervical dilatation was required while doing 
hysteroscopy. In those 6 patients, 1 patient (2%) had submucosal myoma. 
4(8%) patients had proliferative endometrium. Endometrial hyperplasia 
was found in 1 patient (2%) of the 6 patients. 
 
 
   
  
endometr
hyperplas
9(18%) p
had atroph
 
F
0
2
4
6
8
10
12
14
16
18
20
N
o 
of
 P
at
ie
nt
s
In multip
ium. 8(16
ia was f
atients ha
ic endom
igure.7 sh
18
Proliferativ
arous pa
%) patien
ound in 
d myoma 
etrium am
owing hy
8
e Secret
50
tients 14 
ts had se
9 patient
uterus in 
ong mul
sterosco
ory A
Hysterosc
patients 
cretory e
s (18%) 
multiparo
tiparous w
pic diagn
4
trophic
opic diagnos
(28%) h
ndometriu
of multi
us group
omen. 
osis in 50
10
Myoma
is
ad prolif
m. Endo
parous w
.  4(8%) p
 patients
10
Hyperpla
erative 
metrial 
omen. 
atients 
 
. 
sia
  D
with succ
patients (8
 M
Proliferat
Secretory
endometr
observed 
 H
comma sh
basal arte
My
Figure
iagnostic
ess unde
%) parac
yoma w
ive type 
 endome
ium was s
in 10 pati
ysterosco
aped coi
ries. Thes
Atro
oma, 10
Hyperp
.8 showin
 hysteros
r intrave
ervical bl
as seen
of   end
trium w
een in 4 p
ents (20%
pic appe
led arterie
e basal a
phic, 4
lasia, 10
51
g hyster
copy wa
nous sed
ock was u
 in 10 
ometrium
as seen 
atients (8
).  
arance of
s growin
rteries lie
Pr
Secreto
oscopic fi
s perform
ation in 
sed. 
patients
 was see
in 8 p
%). Hype
 prolifera
g in a per
 in the su
oliferative, 
ry, 8
ndings in
ed in 10
46 patien
(20%) in
n in 18 
atients (
rplastic en
tive endo
pendicula
rface of t
18
 our pati
0% of p
ts (92%)
 hystero
patients 
16%). A
dometriu
metrium 
r fashion
he endom
Prolifera
Secretory
Atrophic
Myoma
Hyperpla
 
ents 
atients 
. In 4 
scopy. 
(36%). 
trophic 
m was 
is the 
 to the 
etrium 
tive
sia
52 
 
parallel to one another. The coiled arteries prominently appear in the late 
proliferative endometrium. 
 Hysteroscopic appearance of secretory endometrium is that the 
glandular openings are surrounded by the terminal arterioles. The coiled 
arteries are not visible due to the dense interglandular stroma. The density 
is due to stromal edema and accumulation of secretions. The colour 
changes from pink to ivory. 
 Hysteroscopic diagnosis of endometrial hyperplasia was based 
on one or more of the following features: 
1. Increase in the endometrial thickness- focal or diffuse. 
2. The endometrial surface appears irregular. 
3.  Appearance of cystic spaces protruding into the 
endometrium. 
4.  Increased vascularity and dilated superficial vessels 
on the panoramic view. 
 Endometrial hyperplasia may produce obvious intracavitary 
lesions which appears as white, friable with little or no vessels in 
hysteroscopy. The panoramic view of the endometrial cavity is distorted 
by these lesions. Sometimes endometrial hyperplasia may exist in spite of 
little or no obvious endometrial lesions in hysteroscopy. 
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  The hysteroscopic appearance of low risk endometrial 
hyperplasia includes an increase in the thickness of the endometrium, its 
dyshomogeneous regeneration, increased vascularization and the 
presence of ciliated images, cystic dilatation, increased bleeding, 
polypoid formation, necrotic zones and the concentration and irregular 
arrangement of the glandular openings. 
Leiomyoma: 
 Benign leiomyoma was seen as a mass lesion buldging into the 
endometrium in hysteroscopy. It appears as white spherical masses 
covered with a network of fragile thin-walled vessels when viewed by 
hysteroscope. It can be sessile or pedunculated. 
Endometrial carcinoma: 
  In its initial stages, endometrial cancer shows a papillary 
appearance with irregular polylobate excrescences which are friable and 
partly necrotic or haemorrhagic. Vascularization is irregular and 
increased. Often there is a clear dividing line between cancerous and 
normal endometrium.  
 The procedure was completed after obtaining complete 
hemostasis and directed biopsies are taken from lesions that gave the 
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impression of focal hyperplasia or from uterine walls in case of diffuse 
hyperplasia. 
 Hysteroscopy guided biopsy was taken in all patients included in 
the study. No serious complications were encountered during the 
procedure. The complications usually expected are uterine perforation 
and bleeding. The sensitivity of hysteroscopy was assessed by correlating 
the findings of hysteroscopy with the histopathological examination of 
the tissues obtained. The hysteroscopic findings in the study are: 
Table.10 showing histopathology findings in our patients. 
Hysteroscopy Histopathology 
findings 
Hysteroscopy No.of patient proliferative secretory atrophic 
hyper 
plasia Submucous 
Proliferative 18 19     
Secretory 8  9    
Atrophic 4   4   
Hyperplasia 10    8  
Myoma 10     10 
 
 Figu
 1
endometr
dense str
correspon
vessels gr
 2
subnuclea
ovulatory
Coiling o
eosinophi
h
re.9 show
. In hi
ium are t
oma. It i
ding to t
ow up int
. The ch
r vacuole
 day cor
f spiral 
lic cytopl
atrophic,
yperplasia, 8
leio
ing histo
stopatholo
ubular gl
s due to 
he follicu
o the endo
aracteristi
s in cells 
respondin
arterioles
asm and i
sec
 4
myoma, 10
55
patholog
gy the 
ands with
the estro
lar phas
metrium.
cs of sec
which for
g with lu
 is seen
s dense. 
pr
retory, 9
ical findi
features 
 column
genic act
e of the 
 
retory end
ms the g
teal pha
. The st
oliferative, 19
ngs in ou
found 
ar cells a
ion on th
ovarian c
ometrium
lands con
se in the
roma con
r patient
in prolif
nd surro
e endom
ycle. Art
 are pro
sistent wi
 ovarian 
tains ab
prolifer
secreto
atrophi
hyperp
leiomyo
 
s. 
erative 
unding 
etrium 
eriolar 
minent 
th post 
cycle. 
undant 
ative
ry
c
lasia
ma
56 
 
 3. Endometrial hyperplasia: 
 a.  Simple hyperplasia: 
    Crowded and often cystically dilated glands with some 
outpouching and budding. Glands lined by pseudo stratified nuclei that 
show minimal atypia. 
 b.  Complex hyperplasia (adenomatous hyperplasia): 
       Characterized by more definitive architectural atypia. 
Endometrial glands gives an irregular definition and increasing 
architectural complexity at lower pole. Endometrium appears more 
complex. 
 In our study out of 8patients showing hyperplasia in HPE, 6 
patients (12%) had simple hyperplasia. 2 patients (4%) had complex 
hyperplasia. Both of them underwent hysterectomy and confirmed the 
diagnosis. 
Table.11 showing hyperplasia in HPE 
Total no. of patients with 
hyperplasia in HPE 
8(16%) 
Simple hyperplasia 6(12%) 
Complex hyperplasia 2(4%) 
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 4.  Benign leiomyoma : 
       In histopathology it was seen as bundles of smooth muscle 
interlacing with eosinophilic cytoplasm. Smooth muscle cells are tightly 
packed when compared to the normal myometrium and these tumours 
appear more cellular compared to the normal myometrium with whorled 
appearance. 
Table.12 showing Sensitivity, specificity, predictive value and 
negative    predictive value of Hysteroscopy with HPE 
Variable Sensitivity% Specificity% PPV% NPV%
Proliferative 94.73 100 100 96.87 
Secretory 88.88 100 100 97.61 
Atrophic 100 100 100 100 
Myoma 100 100 100 100 
Hyperplastic 100 95.23 80 100 
 The sensitivity of hysteroscopy in detecting myoma and 
hyperplasia was 100%. For hyperplasia the positive predictive value was 
80%. For atrophic endometrium it hysteroscope was 100% sensitive and 
specific. For proliferative endometrium sensitivity was 94.73% and 
sensitivity for secretory endometrium was 88.88%. 
 
  
               Figure.11a.  Proliferative  Endometrium  
 
 
 
                               Figure.11b   Secretory Endometrium 
  
 
 
Figure.12a.  Simple Hyperplasia 
 
 
 
Figure.12b.  Complex Hyperplasia 
 
 Figure.13a. Leiomyoma Uterus 
 
 
Figure.13b. Atrophic Endometrium 
 
 
 
 
 Figure.10a. Proliferative Endometrium In Hysteroscopy 
 
 
Figure.10b.  Secretory Endometrium in Hysteroscopy 
 
 Figure.10c. Submucous Myoma in Hysteroscopy 
 
 
Figure. 10d.  Atrophic Endometrium in Hysteroscopy  
 
 
  
Figure.10e. Hyperplastic Endometrium in Hysteroscopy. 
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                         DISCUSSION 
 Abnormal uterine bleeding (AUB) represents a notable sign for 
bening and malignant uterine pathology.  AUB was the only indication 
for 48% of 10,020 hysteroscopic examinations preformed according to 
reports in the literature. 1 Abnormal uterine bleeding during any age group 
is of concern and has to be evaluated. Menorrhagia was the most common 
complaint of the patients included in the study, 40 patients (80%), which 
was seen in 4 (8%) of patients in 20-29 years age group, 20 patients 
(40%) in the age group of 30-39years  and 16 patients (32%) of patients 
in the age group of 40-49 years. Others had complaints like 
polymenorrhoea (6 patients) and intermenstrual bleeding (2 patients). 
 Sharp curettage, dilatation and curettage 22 or various other 
intrauterine sampling devices like Pipelle canulla was considered to be 
the most commonly used methods of diagnosis of abnormal uterine 
bleeding before the use of hysteroscope. 26,28,35,39 The success rate of these 
procedures has been viewed in two ways: first is in most of the studies, 
the success rate of the specific method is determined by its ability to 
diagnose endometrial carcinoma. Second is there is no comparative 
studies between endometrial sampling of these studies with hysteroscopic 
endometrial sampling to find out the comparision. 2,5,8 
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 It is shown from a number of studies that biopsy under 
hysteroscopic guidance is superior to other methods like dilatation and 
cirrettage, Pippelle curettage in the evaluation of cause of abnormal 
uterine bleeding. 3,8,10,15,17,22 The correlation of hysteroscopy with the 
endometrial histopathology was statistically significant (p<0.001). While 
evaluating the cause of abnormal uterine bleeding in review 15% of 
patients had intrauterine pathology. The likelihood ratios suggests that 
diagnostic hysteroscopy is both useful tool in dignosing the disease and 
also has a good negative predictive value. 13,15,17,19 Another review which 
analysed the accuracy for endometrial polyps and submucous myomas 
did not reveal any difference. 
 In evaluating the patients with abnormal uterine bleeding, the 
hysteroscopic finding most commonly made out was benign diseases of 
uterus. 10,12,16 like leiomyoma, poliferative and secretory endometrium. 
The patients included in the study are all reproductive age group and no 
case of endometrial carcinoma was made out in our study. In review 
endometrial polyps were reported in 33.9% of hyteroscopies and it was 
confirmed by histopathological study in 27.5% of patients. In our study 
no patient had endometrial polyp which did not go in accordance with the 
review. The occurrence of endometrial polyp increases with age and are 
more commonly seen in postmenopausal age group. 10% of post 
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menopausal bleeding is due to polyp. 63 The study did not go in 
accordance with the review. 
  The most frequent intrauterine pathology made out in 
hysteroscopy was proliferative endometrium (18 patients). The same 
result has been obtained in histopathological study where the most 
frequent finding was also the finding of proliferative endometrium (19 
patients). 20 patients in our study were in the age group greater than 40 
years. In that 5 patients had intrauterine pathology. There was no age 
related statistically significant difference in the incidence of intrauterine 
pathology. Although there were several studies which tells that 
hysteroscope is not much more sensitive in detecting endometrial 
hyperplasia than dilatation and curettage. 41-44 in our study the positive 
predictive value of hysteroscopy in detecting the intrauterine pathology 
was 100% and in endometrial hyperplasia was 80%. The proliferative 
hyperplasia was seen in 18 patients (36%), whereas in histopathological 
examination it was seen in 19 patients (38%). The positive predictive 
value was 100% in detecting proliferative endometrium when correlated 
with the histopathological examination. 
  The secretory endometrium was seen in 8 patients (16%) 
through the hysteroscope. In histopathology it was seen in 9(18%) of our 
61 
 
patients. The positive predictive value was 100% when compared with 
the studies is low. These datas are not in accordance..   
 Hyperplasia was diagnosed in hysteroscopy in 10 patients. Out 
of the 10 patients with hyperplasia in hysteroscopy, two patients 
suspected to have complex hyperplasia. In histopathological examination 
6 patients showed simple hyperplasia and 2 patients suspected to have 
complex hyperplasia was confirmed in HPE. The complex hyperplasia 
was suspected in 2 patients due to the increased vascularity with 
haemorrhagic and necrotic areas and it was proved to be complex 
hyperplasia by the histopathological examination. In complex hyperplasia 
the glands are more markedly crowded and sometimes shows 
architectural abnormalities such as papillary infoldings. 62 So 
hysteroscopy was 100% sensitive and specific in diagnosing complex 
hyperplasia of endometrium. Hysteroscopy has PPV of 80% in 
diagnosing hyperplasia.  
 In 4 patients (8%), the endometrium was atrophic in 
hysteroscopy. The histopathological analysis of the endometrial tissues in 
these patients showed atrophic endometrium in all the 4(8%) of patients. 
100% sensitive and specific in diagnosing atrophic endometrium.  
 The incidence of endometrial malignancy was 1% in Nagele’s 
study and 0.6% by Sciarra and Valle. 46 But in our study no patient had 
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endometrial carcinoma. All the patients included in the group are 
premenopausal of reproductive age group. Only 2 patients (4%) of them 
were above 50 years and possibly this explains the reason why no patient 
in the study was shown to have endometrial carcinoma. Peak incidence of 
endometrial cancer was found in women in their 70s. Overall 80% of 
diagnosis occurs in postmenopausal women older than 55 year. 62 In our 
study to our best no case of endometrial cancer was overlooked. 
 Clark et al 47 proved in his study that the diagnostic hysteroscopy 
is accurate in diagnosing endometrial cancer. It has been said that a thick 
endometrium hinders the view of the uterine cavity in diagnosing the 
uterine pathology. So hysteroscopy alone is not sufficient. Hysteroscopy 
along with biopsy is needed. Hysteroscopy without biopsy is therefore 
unreliable in diagnosing the endometrial malignancy since the difference 
between premalignant lesion and malignant lesion of the endometrium 
may be subtle, and hysteroscopy alone is not sufficient. 23 Moreover 
endometrial biopsy and histopathology of the endometrium is definitely 
needed to establish the diagnosis of endometrial carcinoma, its type and 
grade. Also for optimal visualization, diagnostic hysteroscopy to be 
scheduled in the follicular phase. 
 Many studies have shown a higher detetion of intrauterine 
abnormalities especially fibroids. 39-44,47 In our study only  submucous  
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fibroids were reported. The specificity and sensitivity of TVS in 
diagnosing intrauterine pathology showed considerable variation. Some 
studies showed it as an accurate test with more than 95% sensitivity for 
intrauterine lesions. 39.47 In several other studies it was shown to have 
sensitivity between 60-77%. 12  
  10 patients in our study had myoma which has been diagnosed 
by hysteroscopy.  In histopathology 10 patients had leiomyoma. The 
positive predictive value was 100% in diagnosing the myomas. This is in 
accordance with the review. Overall hysteroscopy proved to be 100% 
specific in diagnosing the myomas. The sensitivity and specificity was 
100% and positive predictive value was 100% in our study for 
submucous myomas. The review of studies shows that TVS has a more 
false negative value in diagnosing intrauterine pathology when compared 
to diagnostic hysteroscopy and SH. 4,8,13 Sonohysterography and 
diagnostic hysteroscopy has good accuracy in diagnosing submucous 
fibroids and endometrial hyperplasia. 39,47 But none of the studies 
included in the review compared both these diagnostic modalities. 
 The postmenopausal age group women were not added in our 
study. The main concern of adding postmenopausal women is that the 
endometrial thickness is lower in postmenopausal women when 
compared to women of reproductive age group. This influences the 
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results of the study. Only one study in the review added postmenopausal 
women where endometrial thickness and detection of endometrial cancer 
or hyperplasia was the outcome and a lower cutoff was used for diagnosis 
which unlikely to influence the results. 27 
 Loeffer 25 in his study showed the diagnostic specificity and 
sensitivity of dilatation and curettage against the hysteroscopic 
assessment and biopsy and showed 65% sensitivity for dilatation and 
curettage and 98% sensitivity for hysteroscopy and biopsy. The 
sensitivity for submucous myoma was 100% in our study when correlated 
with histopathological analysis.  The finding of hyperplasia was in 10 
(20%) patients through hysteroscope and in histopathological analysis it 
was in 8 patients (16%). The positive predictive value was 80%. 
 Out patient hysteroscopy as a mode of diagnostic modality for 
abnormal uterine bleeding has gained popularity and is extremely 
encouraging. Its high diagnostic reliability, less pain, minimally invasive, 
office procedure all these make this diagnostic hysteroscopy an ideal 
method for diagnosis and also for follow up of patients with endometrial 
hyperplasia. The review of the studies about hysteroscopy in abnormal 
uterine bleeding and its Meta analysis showed that diagnostic 
hysteroscopy is accurate in diagnosing intrauterine pathologies. It is 
highly sensitive and is useful clinically. Moreover when compared to 
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other studies. 5,8,11,16,18 our review confirms that diagnostic hysteroscopy 
is safe  and no complication has been in our study. Technical failures and 
patient discomfort were not reported in any of the patients included in our 
study. All the patients taken for the study underwent hysteroscopy 
successfully. 
 The reproducibility of hysteroscopy was not studied in any of the 
studies included. 1-10 There is a possibility of getting inter-rater variability 
in test performance. It occurs both in the sense of estimates of test 
characteristics and in the actual interaction of the diagnostic instrument 
with the patient. This explains some of the marked variability between 
most studies and may impact on the interpretation of the likelihood ratios 
and their application in the evaluation. The absence of the study regarding 
this part makes it difficult to predict what effect variability may have if 
hysteroscopy is repeated. In future studies the inter-rater variability 
should be reported to assess this effect in evaluation of abnormal uterine 
bleeding by diagnostic hysteroscopy. Future studies should include the 
establishment of its clinical usefulness. For example, a testing algorithm 
could be developed where TVS is performed, and in circumstances like 
centrally located fibroids, endometrium greater than 12mm, a saline 
hysterogram is performed. This is then made to compare with the 
diagnostic hysteroscopy. 
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 Hysterectomy specimens were regarded as the criterion which is 
standard for the verification of intrauterine diseases. The specimens 
showed the same results as the histopathology of the hysteroscopic biopsy 
samples in 2 patients with complex hyperplasia. 
 Recently hysteroscopy is performed as a vaginoscopic approach. 
Here no speculum or tenaculum is used and this further reduces the 
discomfort to the patient. 5,8,10 In our study the patients experienced less 
or no discomfort under sedation. Even in the post procedure there was 
remarkably less patient discomfort with the 4.3mm hysterosope, which 
was used in our study. So diagnostic hysteroscopy offers a better 
alternative to dilatation and curettage for the diagnosis of intrauterine 
pathology.  
 All the patients included in the study were counseled about the 
procedure and its importance and ease in diagnosis explained. Informed 
consent obtained. This provided a good environment for the procedure. 
Also the presence of the assisting theatre staff helped in doing the 
procedure easily. In the review a few have used paracervical block for 
hysteroscopy. In our study we used total intravenous anaesthesia 
(sedation) for most of the cases. For 4 patients (8%) we used paracervical 
block. There was no significant difference in the patient discomfort 
between the two. Paracervical block was not preferred since the risk of 
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intravasation and its subsequent side effects. 18-20 Diagnostic outpatient 
hysteroscopy provides more complete information concerning the 
endometrial cavity when compared to dilatation and curettage,22 revealing 
a 20% (10) of submucous myoma in the patients studied. 
 The patients taken for our study are discharged after the 
procedure. Mainly the patients came back for menstrual irregularities. 
The histopathology of them studied and treated accordingly. 
  
68 
 
 
Table.13 showing sensitivity and specificity plot and pooled results of 
diagnostic hysteroscopy in the diagnosis of intracavitary 
abnormalities. 
S.No. Studies Sensitivity (pooled sensitivity=0.94) 
Specificity 
(pooled 
specificity=0.89) 
1. Bender et al 0.98 0.78 
2 Chachia  et al 0.92 0.88 
3. Cochen et al 0.92 1.00 
3 Cicinelli et al 0.96 1.00 
4 Descarques  et al 0.92 0.55 
5 Dueholm  et al 0.84 0.88 
6 Garuti et al 0.94 0.87 
7 Loverro et al 1.00 0.93 
8. Ludwin  et al 0.94 1.00 
9. Ossola et al 0.98 0.63 
10. Paschoupoulos et al 0.94 0.92 
11. Schwarzier et al 0.90 0.91 
12. Sousa et al 0.98 0.71 
13. Towbin et al 0.92 0.39 
14. Our study  1.00 1.00 
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 Analysis of the above data shows that diagnostic hysteroscopy as 
an out patient procedure is a most reliable method in assessing the 
intrauterine pathology in patients of abnormal uterine bleeding. It also has 
higher patient acceptable rate. It is now used as an office procedure for 
the patients with menstrual irregularities and excessive bleeding. It also 
provides the treating  gynaecologist with more information regarding the 
endometrial pathology than the convention dilatation and curettage. 
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Table.14 showing meta-analysis on the diagnostic accuracy of 
hysteroscopy in evaluation of uterine cavity stratified by different 
subgroups. 
 
Studies No. Menopausal status Co 
No. of 
failed 
procedures
Reference 
test 
Inclusion 
criteria 
Bender 
et al 160 
Pre & post 
menopausal 100 Unknown 
Biopsy or 
D&C AUB 
Chachia 
et al 84 Premenopausal 100 Unknown 
Hysterectomy/
operative 
hysteroscopy 
or D&C 
AUB 
Cicinelli    
et al 50 
Pre & post 
menopausal 100 0 Hysterectomy 
Schedulaed 
Hysterectomy 
Cohan       
et al 15 Post menopausal 100 Unknown 
Operative 
hysteroscopy 
or D&C 
PMB or 
USG> 
6mm ET 
Descarques 
et al 38 
Pre & post 
menopausal 100 0 
Biopsy or 
D&C AUB or PMB 
Dueholm 
et  al 108 Premenopausal 98 3 
Hysterectomy 
 
Scheduled 
hysterectomy 
Loverro     
et al 106 Postmenopausal 100 0 Biopsy PMB 
Ludwin      
et al 47 Postmenopausal 100 0 
Hysterectomy 
or operative 
hysteroscopy 
or biopsy 
PMB or 
USG>5mm 
ET 
Ossola       
et al 55 
Pre & post 
Menopausal 100 0 
Operative 
hysteroscopy 
or D&C or 
biopsy 
AUB or PMB 
Schwarzler 
et al 104 
Pre & post 
Menopausal 100 0 Biopsy 
Failed medical 
Therapy in 
AUB 
Sousa        
et al 88 Postmenopausal 86 15 
Biopsy or 
D&C PMB 
Our study 50 Premenopausal 100 0 
Hysteroscopy 
guided 
Biopsy 
AUB 
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  Whenever patients of reproductive age group and also 
postmenopausal group complaints of any menstrual problem it is 
advisable to do an endometrial sampling. It is now easily done through 
hysteroscopy.  Always the diagnostic hysteroscopy is done along with 
biopsy and histopathological analysis correlated. 
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LIMITATIONS 
   The number of patients enrolled in the study was less and so 
statistically significant inferences could not be made with regard to 
various factors. There are also errors and subjective variation in the 
assessment and characterization of lesions observed during the procedure. 
This study cannot be generelised to all socio economic groups, since this 
study is undertaken in lower socio economic group. Also the histological 
correlation between the diagnosis of hysteroscopy and the 
histopathological findings was studied and it showed a good correlation 
which concluded that hysteroscopy is more accurate. The significance of 
the small lesions which was missed by ultrasound and other 
investigations but diagnosed by ultrasound was doubtful.  
 
 
 
 
 
 
 
 
73 
 
SUMMARY 
Title: Role of Diagnostic Hysteroscopy in Evaluation of Abnormal 
Uterine Bleeding in women of reproductive age group and its 
histopathological correlation. 
Sample size: 50 patients. 
Design: Prospective study. 
Procedure done : Hysteroscopy and endometrial sampling and 
Histopathological analysis of the sample. 
 
Study objective: 
 1. To identify the cause of abnormal uterine bleeding. 
2. To identify any endometrial lesions like fibroid or polyp. 
3. To evaluate the endometrial surface for the presence of hyperplasia. 
4. To obtain endometrial curretings for histopathological evaluation 
and its correlation with the hysteroscopic findings. 
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Study Conclusion: 
¾ 44 patients (88%) are multiparous and 6 patients (12%) are 
nulliparous. No difficulty was encountered in insertion of the 
hysteroscope between the two groups. 
¾ 42 patients (84%) had  menorrhagia as  their  compliant. 
¾ 30 patients delivered by vaginal delivery and 14 delivered by 
caesarian section. No difficulty was encountered among them in 
insertion of hysteroscope. 
¾ No patient in the study had any complication during or after the 
procedure. 
¾ 10 patients had submucous myoma in hysteroscopy which was 
proved by the HPE report. 
¾ 4 patients had atrophic endometrium in hysteroscopy confirmed in 
HPE. 
¾ 10 patients had hyperplastic features in hysteroscopy. In that 8 
confirmed to have hyperplasia, 2 had complex hyperplasia and 6 
had simplex hyperplasia. 
¾  18 patients had proliferative endometrium in hysteroscopy. In 
HPE 19 patients had proliferative endometrium. 
¾   8 patients had secretory endometrium in hysteroscopy. In HPE 9 
patients had secretory endometrium. 
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¾  Hysteroscopy was found to be 100% sensitive and specific in 
diagnosis of endometrial lesion. 
¾   No patient included in the study had endometrial carcinoma or 
endometrial polyp.  
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CONCLUSION 
    
 50 patients with abnormal uterine bleeding were included in the 
study. The most common pattern of bleeding in these patients was 
cyclical and excessive bleeding. A few patient had intermenstrual 
bleeding. All the patients  were  in the reproductive age group. 
  Hysteroscopy  was done in all patients with informed consent 
under intravenous anaesthesia. The hysteroscope used for the purpose 
was 4.3mm hysteroscope. This is done as an outpatient procedure and the 
diagnosis arrived.  There was no major complications  and patient 
discomfort was less with this diameter hysteroscope. It proved to be a 
safe and simple procedure in diagnosing intrauterine pathologies and 
various other causes in patients with abnormal uterine bleeding.  
 The 30 degree hysteroscope used provided a clearer view of the 
endometrial cavity and biopsies were taken from sites which was 
suspicious. Even small areas of endometrial thickening, alterations in 
vasculature, consistency of endometrium are  clearly made out with this. 
This facilitated easy biopsy at that site. The pathological correlation was 
also good when the biopsy was taken from the suspiscious sites. 
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  In these group of patients the most common intrauterine 
abnormality was submucous myoma made out by hysteroscope and 
confirmed by histopathological examination. 10 patients had hyperplastic 
endometrium. Those patients suspected to have complex hyperplasia 
through hysteroscope was confirmed by HPE. The hysteroscopic findings 
were correlated  with the histopathological findings.  
 The results obtained showed a sensitivity of 100% and positive 
predictive value of  100%  for hysteroscopy in diagnosing endometrial 
pathology. Considering all the factors together diagnostic hysteroscopy is 
both accurate and a feasible investigation in evaluating various causes of 
abnormal uterine bleeding  especially the endometrial  pathologies.   
 
 
 
BIBILIOGRAPHY 
 
1.   Emanuel MH, Verdel MJC, Stas H,Wamsteker K,Lammes FB. 
An audit of true prevalence of intra uterine pathology: the 
hysteroscopical findings controlled for patient selection in 1202 
patients with abnormal uterine bleeding. Gynecol Endosc 1995; 
4:237-41. 
2.  Gimpleson RJ, Rappold HO. A comprehensive study between 
panoramic hysteroscopy with directed biopsies and dilatation 
and curettage. A review of 276 cases. Am J Obstet Gynecol 
1988; 158:489-92 
3.   Stamatellos P. stamatopoulos D. Rousso E.Asimakopoulos C. 
Stamatopoulos   I. Bontis      Investigation of abnormal uterine 
bleeding in perimenopausal  women by hysteroscopy and 
endometrial biopsy Gynecol Surgery (2005) 2: 51-55. 
4.  Elisabeth Krampl, Tom Bourne < Heidi Hurlen-Solbakken, 
OlAnteverted Istre. Transvaginal ultrasonography  
sonohysterography  and operative hysteroscopy for the 
evaluation of abnormal uterine bleeding. Acta Obstet Gynecol 
Scand 2001; 80: 616-622. 
5.   Serden S. Dignostic hysteroscopy to evaluate the cause of 
abnormal uterine bleeding. Obstet Gynecol Clin North Am 2000; 
27:277-86. 
6.    Goldstein RB , Bree RL, Benson CB, Benacerraf BR, Bloss JD, 
Carlos R, et al. Evaluation of the woman with postmenopausal 
bleeding : Society of Radiologists in  Ultrasound – Sponsored  
Consensus Conference statement. J Ultrasound Med 2001; 20: 
1025 36.  
7.  Clark TJ, Voit D, Gupta JK, Hyde C, Song F, Khan KS. 
Accuracy of hysteroscopy in the diagnosis of endometrial cancer 
and hyperplasia: systematic quantitative review. JAMA 2002; 
288: 1610-21. 
8.  Faraquhar C, Ekeroma A, Furness S, Arroll B. A systematic 
review of transvaginal ultrasonography, sonohysterography and 
hysteroscopy for the investigation of abnormal uterine bleeding 
in perimenopausal  women. Acta Obstet Gynecol Scand 2003; 
82: 493-503. 
9.  Van Dongen H, de Kroon C, Jacobi C, TRimbos B, Jansen F. 
Diagnostic hysteroscopy in abnormal uterine bleeding:  a 
systematic review and meta-analysis. BJOG 2007; 114:664-675. 
10.  OlAnteverted Istre Erik Qvigstad. Current treatment options for 
abnormal uterine bleeding:an evidence – based approach. Best 
Practice & Research Clinical Obstetrics and Gynecology Vol. 
21, No. 6, pp. 905-913, 2007. 
11.  Ricardo Bssil Lasmar, Rog_erio Dias, Paulo Roberto Mussel 
Barrozo, Marco Aur_elio Pinho Oliveria, Evandro  da Silva 
Freire  Countinho , and Daniela Baltar da Rosa. Prevalence of 
hysteroscopic findings and histologic diagnosis inpatients with 
abnormal uterine bleeding. Fertility and Sterility _ Vol. 89, No.6, 
June 2008 
12.  Selvaggi L, Cormio G, Ceci O, Loverro G, Cazzolla A, 
Bettocchi S. Hysteroscopy does not increase the risk of 
microscopic extrauterine spread in endometrial carcinoma. Int J 
Gynecol Cancer 2003; 13:223-7. 
13.  Schawarzler p, Concin H, Bosch H, Berluger A, Wohlgannt K, 
Collins WP, Bourne TH. An evaluation of sonography and 
diagnostic hysteroscopiy for the assessment of intrauterine 
pathology. Ultrasound  Obstet and Gynecol 1998; 11:337-42. 
14.   Jaeschke R, Guyatt GH, Sackett DL. User`s guides to the 
medical literature.  III. How to use an article about a diagnostic 
test. B. what are the results and will they help me in caring for 
my patients ? The Evidence Based medicine Working Group. 
JAMA 1994; 271: 703 -7.  
15.  Valle RF (1981) Hysteroscopic evaluation of patients with 
abnormal uterine bleeding. Surg Gynecol Obstet 153:521-526. 
16.  Azzena A, Pellizzrari P, Ferrara A. Diagnosis of endometrial 
pathology:  Comparison between hysterosonography , 
hysteroscopy and histologic findings. Int J Gynaecol Obstet 
1999;11:112-15.  
17.  Clark T, Bakour SH, Gupta JK, Khan KS. Evaluation of 
outpatient hysteroscopy and ultrasonography in the diagnosis of 
endometrial disease. Obstet Gynecol 2002 ; 99: 1001-7.  
18.  Bettochi S, Selvaggi L. A vaginoscopic approach to reduce the 
pain of office hysteroscopy. J Am Assoc Gynecol Laparosc 
1997; 4: 255-8 .  
19.  Kremer K, Duffy S, Moroney M Patient satisfaction with 
outpatient hysteroscopy versus day case hysteroscopy; 
randomized controlled trial. BMJ 320: 279-282. 2000. 
20.  De Jong P , Doel F, Falconer. Outpatient Diagnostic 
hysteroscopy. Br J Obstet Gynaecol 1990: 97: 299-303.  
21.    Evangels D. Alexopoulos, Toby N. Fay and Chantal D. Simonis 
A review of 2581 outpatient diagnostic hysteroscopies in the 
management of abnormal uterine bleeding   Gynecological 
Endoscopy 1999 8 , 105-110. 
22.    MacKenzie IZ, Bibby JG. Critical assessment of dilatation and 
curettage in 1029 women. Lancet 1978; ii: 566-8. 
23.   Lewis BV. Hysteroscopy in gynecological practice. Journal of 
the Royal Society of Medicine 1984: 77: 235-7. 
24.    Naegle F, O`Connor H  DAntevertedies A, Badawy A, 
Mohamed H, Magos A. 2500 outpatient diagnostic 
hyseroscopies Obstetricss and Gynecology 1996 ; 87-92. 
25.    Loffer FD. Hysteroscopy with selective endometrial sampling 
compared with D&C for abnormal uterine bleeding: the value of 
a negative hysteroscopic vie. Obstetrics and gynecology 1989; 
73: 16-20.  
26.   Bronz L. Hysteroscopy in the assessment of postmenopausal 
bleeding. Contrib. Gynecol Obstet 2000; 20: 51-9.  
27.    Mettler L, Wendland EM, Pttel P, Caballero, Schollmeyer T. 
Hysteroscopy : an analysis of 2 year experience. JSLS 2002; 6: 
196-7. 
28.   Alexopaoulos ED, Simonis CD Kidsley S, Fay Toby N. The 
value of outpatient hysteroscopy in the management of 
postmenopausal bleeding: a review of 862 cases. Gynaecol 
Endosc 2000; 9: 107-12. 
29.   Bender R, Rzepka-Gorska I. Diagnostic hysteroscopy after D&C 
in women with perimenopausal bleeding. Ginekol Pol 2002; 73: 
577-82.  
30.  Dueholm M, LundorfE, Sorensen JS, Ledertoug S, Olesen F, 
Laursen H. Reproductibility of evaluation of the uterus by 
tranvaginal sonography, hysterosonographic examination, 
hysteroscopy and magnetic resonance imaging. Hum Reprod 
2002; 17: 195-200.  
31.  Bozzini P (1807) Delichtleiter oder Beschreibung einer 
einfachen und ihrer Anwendung zur Erleuchtung innerer 
Hohelen und Zwischenraume des lebenden animalischen Korpes. 
Verlag des lands Industrie Comptoir , Weimar 
32.  Siegler AM, Kemmnn E, GEntlie GP (1976) Hysteroscopic 
procedures in 257 patients. Fertil  Steril 27: 1267 – 73.  
33.  Valle RF (2007) Development of hysteroscopy: from a dream to 
a reality, and its linkage to the present and future. J Minim 
Invasive Gynecol 14(4): 407-418.  
34.  Kremer K, Duffy S Moroney m Patient satiafication with 
outpatient hysteroscopy versus day case hysteroscopy: 
randomized controlled trial. BMJ 320: 279-82. 2000.  
35.  N. Markis & E. Vomvolaki & G. Partsinevelos & G. Mantzaris& 
J. Chatzipapas & A. Antsaklis Evaluation of office hysteroscopy 
in premenopausal and post-menopausal women: experience with 
2225 cases. Eur Clinics Obstet Gynecol (2008) 3:113-116. 
36.   Cicinelli E, Matteo M, Causio F, Schonauer LM, Pinto V, 
Galntio P (2001) Tolerability of the mini-pan-endoscopic 
approach (transvaginal hydrolaparoscopy and minihysteroscopy) 
versus hydrosalpingography in an outpatient infertility 
investigation. Fertil Steril 76: 1048-1051. 
37.  Paschopoulos M, Paraskevaidis E, Stefanidis K , Kotinas G, 
Lolis D (1997)  Vaginoscopic approach  to outpatient. 
38.  Dukanovic S, Canic T (2007) The value of hysteroscopy in 
perimenopausal women   (Vrijednost histeroskopije u 
perimenopauzi.Acta Med Croat 61 (2):185-190 
39.  Loverro G Bottocchi S , Cormio G ,Nicolardi V, Greco P, 
Selvaggi L (1999) Transvaginal sonography and hysteroscopy in 
postmenopausal uterine bleeding.Maturitas 33(2):139-144 
40.  Rock JA,Thompson JD (1997) Te Linde’s operative gynecology, 
8th edn.RAnteverteden, Philadelphia, pp 469-670 
41.  UnoLH, Sugimoto O, CaRetrovertedalho FM, Bagnoli VR, 
Fonseca AM, Pinotti JA. Morphologicac hysteroscopic criteria 
suggestive of endometrial hyperplasia. International Journal of 
Gynecology a nd Obstetrics 1995;49: 35-40 
42.   Ben –Yehuda OM, Kim YM, Leuchter RS. Does hysteroscopy 
improve upon sensitivity of dilatation and curettage in the 
diagnosis of endometrial hyperplasia or carcinoma? 
Gynecological Oncology 1998; 67(1): 4-7 
43.  DeWit AC, Vleugels MP, De Kruif JH. Diagnostic hysteroscopy 
: a valuable diagnostic tool in the diagnosis of structural 
intracAntevertedital pathology and endometrial hyperplasia or 
carcinoma? Six years of experience with non clinical diagnostic 
hysteroscopy.Eur J Obstet Gynecol Reprod Biol (Ireland) 
2003;110:79-82. 
44.  Triolo O Antico F, Palmara V, Benedetto V, Panama S, Nicotina 
PA. Hysteroscopic Findings of endometrial carcinoma, 
Evaluation of104 cases.Eur J Gynaecol Oncol 2005;26:434_6. 
45.   Negele F, O ‘Connor H, DAntevertedies A, Badawy A, 
Mohamed H ,Magos A,2500 outpatients diagnostic 
hysteroscopies Obstetrics and Gynaecology 1996;88:87-92 
46.     Sciarra JJ,Valle RF, A clinical experience with 320 patients 
American Journal of Obstetrics and Gynecology 1977;127:340-8 
47.  Clark T, Bakour SH, Gupta JK, Khan KS.Evaluation of 
outpatient hysteroscopy and ultrasonography in the diagnosis of 
endometrial disesse. Obstet Gynecol 2002;99:1001-7. 
48.    J Obstet Gynaecol India 2011 Oct;61(5):546-9. Epub 2011 Nov. 
49.   Hatasaka H: The evaluation of Abnormal Uterine Bleeding 
clinical Obstet Gynaecol.2005;48(2):258-73 
50.   International Journal of Gynecology and Obstetrics 113 (2011) 
3-13. FIGO classification system (PALM-COEIN) for causes of 
AUB in nongrAntevertedid women of reproductive age. 
 51.  Vilos GA.Lefebvre G, GrAntevertedes GR, Guidelines for the 
management of abnormal uterine bleeding J Obstet Gynaecol 
can 2001;23(8);704-9 
52.   SOGC clinical practice guideline, No. 292, May 2013). 
53.  Lefebvre G.Vilos G, Allaire C, Jaffrey J. The management & 
uterine leiomyomas, J Obstet Gynaecol can 2003;128:1-10.) 
54.   SEER cancer statistics review,1973-1996 
55.   Berek & novak’s Gynaecology, 15th edition 
56.   Te Linde’s operative gynaecology tenth edition, Rock and Jones.  
57.  Kurman RJ, Kaminski PF, Norris HJ. The behAntevertedior of 
Endometrial hyperplasia: a long term study of “untreated” 
hyperplasia in 170 patients. Cancer 1985:56:403-12. 
58.  TAntevertedassoli F, Kraus FT. Endometrial lesions in uteri 
resected for atypical endometrial hyperplasia. Am J Clin Pathol 
1978:70:770-9. 
59.  Hunter JE, Tritz DE, Howell MG, et al. The prognostic and 
therapeutic implications of cytologic atypia in patients with 
endometrial hyperplasia Gynecol Oncol 1994:55:66-71. 
60.  Farquahar C, Ekeroma A, Furness S, et al. A systematic review 
of transvaginal ultrasonography, sonohysterography and 
hysteroscopy for the investigation of abnormal uterine bleeding 
in premenopausal women. Acta Obstet Gynecol Scand. 
2003:82:493-504. 
61.  ACOG practice bulletin No.14: Management of anovulatory 
bleeding. Int J Gynecol  Obstet 2001;72(3):263-71. 
62.   Williams Gynaecology by Hoffman, Schorge, Schaffer, 
Halvorson, Bradshaw, Cunningham-Second edition. 
63.   Hacker NF, Moore JG. Essentials of Obstetrics and 
Gynaecology, 3rd edition WB Saunders, 1998. 
64.   Jeffcoate TNA. Principles of Gynaecology (3rd edition). 
Butterworth: London 1967;91-100. 
65.   Baggish MS. Contact hysteroscopy: a new technique to explore 
the uterine cAntevertedity. Obstet Gynec 1979;54:350. 
66.   Symmers W St. C. Systemic Pathology (2nd edition). Churchill 
Livingstone: Edinburgh. 1970; 4: 1661-7. 
67.   Fox H. The Endometrium. In; Anderson (Ed): Muir’s Textbook 
of Pathology 11th edition. Arnold: London. 1980:947-8. 
68.   Vancaillie T. Hysteroscopic evaluation of hormonal influence on 
the endometrium. In Van der Pas H, Van Herendael BJ, B. Van 
Lith D (Eds): Hysteroscopy MTP Press, Lancaster 1983;101-13. 
69.    Gompel A Anatomie pathologique: gynecologique obstetricale. 
Arscia Brussels 1963;198-9. 
70.    Blaunstein A. Normal Menstrual cycle. In Interpretation of 
Biopsy of the Endometrium. RAnteverteden Press: Newyork 
1980; 13-30. 
71.    Junquera LC, Carneiro J, Contopoulos A. The female 
reproductive system. In Basic Histology 2nd Lange, Los Altos 
1977; 437-9.   
  
PROFORMA 
 
Name    :                                               Age :    Unit : 
IP/OP No. :            DOA        DOS                  DOD 
Socioeconomic status : 
Parity index   : 
Chief complaints  : 
Menstrual history  : 
Pattern of bleeding  : 
1. Cyclical and excessive 
2. Polymenorrhoea 
3. Intermenstrual 
 
Associated symptoms: 
Marital H/O  : 
Obstetric H/O : 
LCB   : 
No. of abortion : 
Spontaneous : 
Induced   : 
Contraception practiced/not :  If yes 
Natural   : 
Barrier   : 
OCP   : 
IUCD   : 
Sterilized   :   Yes       :    PS/LS/interval sterlisation 
General examination : 
Built 
Pallor 
Pedal edema 
Temperature 
Breast 
Thyroid 
Pulse rate 
BP 
CVS 
RS 
P/A 
VIA/VILI 
P/V 
 
 
Investigations: 
Hb  
Urine routine  
Blood group  
TC,DC,PCV  
Platelet count  
BT/CT  
Urea, creatinine  
Sugar  
VDRL/HIV/HbsAG  
Chest x-ray  
ECG  
PAP smear  
Ultrasound  
Anaesthesia   : 
Distension medium : 
Hysteroscopic findings : 
Findings: 
 
Endocervical canal  
Internal os  
Tubal ostia  
Endometrial cavity  
Glandular pattern  
Vascular pattern  
 
 
Histopathological report of  Hysteroscopic endrometrial sample : 
Hysterectomy  : 
Histopathological report  Hysterectomy specimen : 
  
CONSENT FORM 
 
 Yourself Mrs. …………................................……… are being 
asked to be a participant in the research study titled “ROLE OF 
DIAGNOSTIC HYSTEROSCOPY IN EVALUATION OF 
ABNORMAL UTERINE BLEEDING IN WOMEN OF 
REPRODUCTIVE AGE GROUP AND ITS 
HISTOPATHOLOGICAL CORRELATION”  in CMC Hospital, 
Coimbatore, conducted by Dr. L.LATHA, Post Graduate student, 
Department of Obstetrics and Gynaecology, Coimbatore Medical 
College. You are eligible after looking into the inclusion criteria. You can 
ask any question you may have before agreeing to participate. 
RESEARCH BEING DONE 
ROLE OF DIAGNOSTIC HYSTEROSCOPY IN EVALUATION 
OF ABNORMAL UTERINE BLEEDING IN WOMEN OF 
REPRODUCTIVE AGE GROUP AND ITS 
HISTOPATHOLOGICAL CORRELATION 
PURPOSE OF RESEARCH 
 To study the role diagnostic hysteroscopy in evaluating the various 
causes of AUB. 
DECLINE FROM PARTICIPATION  
You have the option to decline from participation in the study existing 
protocol for your condition.  
  
 PRIVACY AND CONFIDENTIALITY 
Privacy of individuals will be respected & any information about you or 
provided by you during the study will be kept strictly confidential. 
AUTHORISATION TO PUBLISH RESULTS 
Results of the study may be published for scientific purposes and /or 
present to scientific groups.  
STATEMENT OF CONSENT  
I volunteer and consent to participate in this study. I have read the 
consent or it has been read to me. The study has been fully explained to 
me and I may ask questions at any time. 
………………………                                   ……………….........……… 
Signature / left thumb impression             Date: 
(Volunteer) 
…………………………..                         ………………….............……. 
Signature of witness 
 
 
 
 
 
 
KEYWORDS TO MASTER CHART 
SES    -  Socioeconomic Status 
C/O  -   Complaints Of 
H/O  -  History Of 
M  -  Months 
RMP  -  Regular Menstrual Cycles. 
EPMB  -  Excessive Premenstrual Bleeding. 
CYL  -  Cyclical 
ACYL  -  Acylical 
LN  -  Labour Natural 
PS   -   Puerperal Sterilisation 
IS  - Interval Sterilisation. 
LS  - Laproscopic Sterilisation 
IMB  -  Inter Menstrual Bleeding 
NUL  -  Nulliparous. 
P  -  Parity 
L  -  Live child. 
A  -  Abortion. 
Polymeno -  Polymenorrhoea. 
WD  -  White Discharge. 
AV   -  Anteverted. 
RV  -  Retroverted. 
WKS  -  Weeks 
NS  -  Normal Saline 
TIVA  -  Total Intra Venous Anaesthesia 
PCB  -  Para Cervical Block. 
N  -  Normal 
Intr  -  Intermediate 
Infl  -  Inflammatory. 
USG  -  Ultrasonogram 
ECC  -  Endo Cervical Canal 
TO  -  Tubal Ostia 
E/G  -  External Genitalia 
LE  -  Local Examination. 
PR  -  Pulse Rate. 
BP  -  Blood Pressure. 
P/A  -  Per Abdomen 
Hb%  -  Haemoglobin 
UCL  -  Uterocervical Length. 
DIS  -  Distension medium 
Anaes  -  Anaesthesia 
S/T  -  Sterilisation  
A.O.M  - Age Of Menarche 
O/H  - Obstetric History 
S. 
No Name Age I.P.NO SES Parity D.O.A D.O.S C/O 
Duratio
n 
Previous 
Menstrual 
H/O 
A. 
O. 
M 
Bleeing 
pattern 
Asso 
C/O O/H S/T 
1 Fathimamary 43 23228 Low P3L 22.4.13 24.4.13 MENORRHAGIA 6  M RMP3/30 13 EPMB NO LN PS 
2 Thilagavathy 42 25184 Low P2L2 2.5.13 4.5.13 MENORRHAGIA 5M RMP3/32 14 CYL NO LN IS 
3 Prema latha 46 30481 Low P2L2 2.5.13 24.5.13 MENORRHAGIA 1 YR RMP5/30 12 ACYCL NO LN NO 
4 Latha 33 30484 Low P2L2 22.5.13 24.5.13 MENORRHAGIA 2M RMP3/30 13 CYC NO LN PS 
5 Sheela 36 32090 Low NUL 28.5.13 1.6.13 POLYMENO 3M RMP428 11 ACYCLI NO LN NO 
6 Thangam 50 28875 Low P3L3 28.5.13 1.6.13 MENORRHAGIA 15M RMP3/30 13 IMB NO LN IS 
7 Neelavathy 40 35395 Low P3L4 13.6.13 15.6.13 MENORRHAGIA 13M RMP5/35 12 EPMB NO CS PS 
8 Pappathy 43 35400 Low P2L2 6.6.13 15.6.13 MENORRHAGIA 17M RMP3/30 13 IMB NO CS IS 
9 Latha 42 37798 Low P2L2 13.6.13 26.6.13 MENORRHAGIA 11M RMP3/30 14 CYC NO CS IS 
10 Revathi 36 3846 Low P3L2 25.6.13 29.6.13 MENORRHAGIA 22M RMP3/30 12 CYC NO CS PS 
11 Selvi 35 3845 Low P3L3 25.6.13 29.6.13 MENORRHAGIA 6M RMP3/40 13 ACYC WD CS IS 
12 Pongiyammal 42 441 Low P5L4 1.1.13 4.1.13 MENORRHAGIA 13M RMP3/30 11 IMB NO LN IS 
13 Gandhimathi 47 1303 Low P3L3 1.1.13 11.1.13 MENORRHAGIA 16M RMP4/35 13 ACY NO LN IS 
14 Leelavathy 37 3020 Low P3L3 17.1.13 18.1.13 MENORRHAGIA 22M RMP3/30 12 CYC NO LN PS 
15 Muthammal 39 3035 Low P4L2 14.1.13 18.1.13 MENORRHAGIA 5M RMP6/30 13 IMB NO LN NO 
16 Kalamani 45 3109 Low P3L3 28.1.13 1.2.13 MENORRHAGIA 6M RMP3/30 12 EPMB NO LN IS 
17 Kameshwari 35 3769 Low P3L2 28.1.13 1.2.13 POLYMENO 14M RMP3/30 13 CYC NO LN PS 
18 Thangamani 34 7299 Low P1LO 25.1.13 1.2.13 MENORRHAGIA 22M RMP4/35 11 CYC NO CS NO 
19 Jothimani 42 7274 Low P2L2 13.2.13 15.2.13 MENORRHAGIA 26M RMP3/30 13 ACYCL NO CS PS 
20 Rathna 29 14064 Low NUL 17.3.13 19.3.13 METRORRHAGIA 13M RMP5/30 12 IMB NO CS NO 
21 Vijayalakshmi 45 16424 Low P3L3 20.3.13 23.3.13 METRORRHAGIA 22M RMP3/30 12 IMB WD LN PS 
22 Kani 40 16958 Low P2A1 19.3.13 22.3.13 MENORRHAGIA 14M RMP5/32 11 CYC NO LN NO 
23 Vijayalakshmi 49 18804 Low NUL 25.3.13 2.4.13 MENORRHAGIA 15M RMP3/30 11 CYC NO LN NO 
24 Rajalakshmi 41 18419 Low P3L3 27.3.13 2.4.13 POLYMENO 20M RMP3/28 13 ACYC NO CS PS 
25 Maheswari 47 22089 Low NUL 1.4.13 2.4.13 MENORRHAGIA 22M RMP3/30 12 ACYC NO CS NO 
26 Jeyalakshmi 26 18854 Low P2L2 1.4.13 2.4.13 MENORRHAGIA 4M RMP5/30 11 IMB NO LN PS 
MASTER  CHART 
  
S. 
No Name Age I.P.NO SES Parity D.O.A D.O.S C/O 
Duratio
n 
Previous 
Menstrual 
H/O 
A. 
O. 
M 
Bleeing 
pattern 
Asso 
C/O O/H S/T 
27 Vijaya 48 23544 Low P2L1 18.4.13 23.4.13 MENORRHAGIA 6M RMP3/30 13 IMB NO LN NO 
28 Saroja 42 29227 Low P3L3 25.4.13 30.4.13 MENORRHAGIA 5m RMP5/35 12 EPMB NO LN IS 
29 Selvi 40 28017 Low P2L2 28.4.13 30.4.13 MENORRHAGIA 9m RMP3/30 15 CYC WD CS PS 
30 Mahalakshmi 30 30297 Low NUL 22.5.13 24.5.13 MENORRHAGIA 11m RMP4/30 12 CYC NO CS NO 
31 Vijayalakshmi 41 32143 Low P2L2A1 3.6.13 5.6.13 POLYMENO 12m RMP3/28 13 ECYC NO LN PS 
32 Sulochana 40 33688 Low P3L3 12.6.13 18.6.13 MENORRHAGIA 10m RMP3/30 11 EPMB NO LN IS 
33 Subbulakshmi 46 37598 Low P1L1 22.6.13 25.6.13 MENORRHAGIA 16m RMP3/30 16 IMB NO CS NO 
34 Mariyammal 46 37548 Low P2L2 20.6.13 25.6.13 MENORRHAGIA 12m RMP3/30 13 IMB NO CS PS 
35 Palaniyammal 40 38281 Low P4L4A1 26.6.13 28.6.13 MENORRHAGIA 28m RMP5/30 12 IMB NO CS PS 
36 Lakshmi 41 39087 Low P3L2A1 28.6.13 1.7.13 POLYMENO 12m RMP3/30 12 CYC NO LN PS 
37 Primala 40 41325 Low P2L2 12.6.13 18.7.13 MENORRHAGIA 12m RMP4/30 12 CYC WD LN IS 
38 Neelammal 50 38216 Low P4L3 12.6.13 18.7.13 MENORRHAGIA 3m RMP3/30 13 ECYC WD LN PS 
39 Sarojini 37 37682 Low P2L2 28.5.13 15.7.13 MENORRHAGIA 7m RMP3/30 14 ECYC NO LN PS 
40 Fathima 49 44481 Low P4L4A1 26.6.13 26.7.13 MENORRHAGIA 9m RMP5/32 11 EPMB NO LN PS 
41 Dhanalaksmi 39 45368 Low P3L2A1 18.7.13 26.7.13 MENORRHAGIA 8m RMP3/30 13 CYC NO LN IS 
42 Indrani 37 46761 Low P2L2 27.7.13 6.8.13 MENORRHAGIA 10m RMP3/30 12 CYC NO LN PS 
43 Mary 48 47325 Low P3L2 10.8.13 14.8.13 METRORRHAGIA 11m RMP5/30 13 EPMB NO CS IS 
44 Renuka 43 50708 Low P2L2 25.8.13 30.8.13 MENORRHAGIA 21m RMP3/30 13 CYC NO LN PS 
45 Sameena 40 53056 Low P2L2 1.9.13 3.9.13 POLYMENO 2m RMP4/32 13 CYC NO LN IS 
46 Savithiri 40 49881 Low P1L1 1.9.13 3.9.13 MENORRHAGIA 6m RMP3/30 11 ECYC WD LN NO 
47 Saraswathy 46 50664 Low NUL 27.7.13 3.9.13 MENORRHAGIA 7m RMP4/35 10 ECYC NO CS NO 
48 Prema 39 50132 Low P1L2 24.7.13 3.9.13 MENORRHAGIA 11m RMP3/30 12 IMB NO CS NO 
49 Sivagami 45 53344 Low P3L3 1.9.13 4.9.13 MENORRHAGIA 14 RMP3/30 11 IMB NO LN PS 
50 Jeyamani 33 52112 Low P2L2 2.9.13 6.9.13 MENORRHAGIA 6m RMP3/30 13 CYC NO LN IS 
S.NO PR BP P/A L/E of E/G VIA 
VILI 
P/V Hb% Pap 
Smear 
UCL Dis Anaes 
1 80 N NAD NAD N Anteverted, Normal 9.6 N 8 NS TIVA 
2 84 N NAD NAD N Anteverted  12wks 9.8 Intr 8.5 NS TIVA 
3 74 N NAD NAD N Anteverted, Normal 10.2 N 11 NS TIVA 
4 76 N NAD NAD N Anteverted,Normal 10 N 7 NS TIVA 
5 76 N NAD NAD N Retroverted,12wks 10.8 N 8 NS TIVA 
6 78 N NAD NAD N Anteverted,14wks 8.6 N 9 NS TIVA 
7 86 N NAD NAD N Anteverted,10wks 8.8 N 8.5 NS PCB 
8 82 N NAD NAD N Retroverted, Normal 9.8 N 8 NS TIVA 
9 80 N NAD NAD N Anteverted,8wks 11 Intr 8 NS TIVA 
10 88 N NAD NAD N Anteverted 10wks 10.2 N 8 NS TIVA 
11 74 N NAD NAD N Anteverted,12wks 8.6 Infl 8.5 NS TIVA 
12 78 N NAD NAD N Anteverted,Normal 8.8 N 9 NS TIVA 
13 78 N NAD NAD N Anteverted 14wks 9 N 9 NS TIVA 
14 80 N NAD NAD N Retroverted,12wks 9.4 N 8.5 NS TIVA 
15 84 N NAD NAD N Anteverted,Normal 8.4 N 8 NS TIVA 
16 86 N NAD NAD N Anteverted ,10wks 8.8 N 8 NS TIVA 
17 74 N NAD NAD N Anteverted,12wks 9.0 N 8.5 NS TIVA 
18 74 N NAD NAD N Anteverted,12wks 9.6 Int 8 NS TIVA 
19 76 N NAD NAD N Anteverted, Normal 9.6 N 8 NS TIVA 
20 80 N NAD NAD N Anteverted, Normal 9.4 Int 8.5 NS TIVA 
21 88 N NAD NAD N Retroverted,14wks 10.2 N 9 NS PCB 
22 78 N NAD NAD N Retroverted,12wks 8.6 N 9.5 NS TIVA 
23 86 N NAD NAD N Retroverted,12wks 8.8 N 8 NS TIVA 
24 84 N NAD NAD N Anteverted,10wks 9.4 N 8 NS TIVA 
25 80 N NAD NAD N Anteverted,10wks 9.6 N 8 NS TIVA 
26 82 N NAD NAD N Anteverted,Normal 8.8 N 8.5 NS TIVA 
27 78 N NAD NAD N Anteverted,Normal 8.4 Inf 8 NS TIVA 
28 72 N NAD NAD N Retroverted10wks 8.2 N 9.5 NS TIVA 
29 74 N NAD NAD N Anteverted, Normal 9.2 N 8.5 NS TIVA 
  
  
S.NO PR BP P/A L/E of E/G VIA 
VILI 
P/V Hb% Pap 
Smear 
UCL Dis Anaes 
30 78 N NAD NAD N Anteverted, Normal 10.2 Int 8.0 NS TIVA 
31 80 N NAD NAD N Retroverted, Normal 9.6 Inf 9.5 NS TIVA 
32 76 N NAD NAD N Anteverted,8wks 8.4 Int 9 NS PCB 
33 74 N NAD NAD N Anteverted,10wks 8.4 N 8.5 NS TIVA 
34 82 N NAD NAD N Retroverted,12wks 9.6 N 8.5 NS TIVA 
35 86 N NAD NAD N Anteverted,8wks 8.8 N 8 NS TIVA 
36 80 N NAD NAD N Anteverted,10wks 10.6 N 8 NS TIVA 
37 84 N NAD NAD N Anteverted,10wks 9 Inf 9 NS TIVA 
38 80 N NAD NAD N Anteverted,12wks 8. Int 9 NS TIVA 
39 88 N NAD NAD N Retroverted,8wks 9.6 N 9.5 NS TIVA 
40 82 N NAD NAD N Anteverted, Normal 9.5 Int 8.5 NS TIVA 
41 76 N NAD NAD N Anteverted,12wks 9.3 Int 8.0 NS TIVA 
42 76 N NAD NAD N Anteverted, Normal 9.8 n 7 NS TIVA 
43 78 N NAD NAD N Anteverted, Normal 8.0 N 7.5 NS TIVA 
44 80 N NAD NAD N Retroverted, Normal 8.7 N 10 NS TIVA 
45 84 N NAD NAD N Anteverted,10wks 10.4 N 9.5 NS TIVA 
46 88 N NAD NAD N Anteverted,12wks 9.5 Int 8 NS TIVA 
47 80 N NAD NAD N Anteverted,16wks 8.8 N 7.5 NS PCB 
48 78 N NAD NAD N Anteverted,12wks 9,6 Inf 8 NS TIVA 
49 74 N NAD NAD N Anteverted, Normal 8.9 N 10 NS TIVA 
50 76 N NAD NAD N Retroverted,10wks 10.7 N 8.5 NS TIVA 
S.No. HPE No. USG ECC T.O Endometrial cavity Vascularity HPE 
1 G533 N N Patent Proliferative endometrium No Proliferative endometrium 
2 G590 Bulky uterus N Patent Secretory endometrium No Secretory endometrium 
3 G710 Thickened endometrium N Patent Proliferative endometrium No Proliferative endometrium 
4 G741 Bulky uterus N Patent Submucous myoma No Leiomyoma with early proliferative 
endometrium 
5 G765 N N Patent Proliferative endometrium No Secretyory endometrium 
6 G763 N N Patent Submucous myoma No Leiomyoma with late proliferative 
endometrium 
7 G842 Submucous myoma N Patent Submucous myoma No Leiomyoma with secretory endometrium 
8 G844 N N Patent Proliferative endometrium No Late proliferative endometrium 
9 G902 Bulky uterus N Patent Secretory endometrium No Secretory phase-no hyperplasia 
10 G928 Thickened  endometrium N Patent Hyperplastic  endometrium No  Simple hyperplasia 
11 G930  intramural myoma N Patent Proliferative endometrium No Early proliferative with no hyperplasia 
12 G08 N N Patent Atrophic endometrium No Atrophic endometrium 
13 G24 Ovarian cyst N Patent Proliferative endometrium No Late proliferative endometrium 
14 G70 Bulky uterus N Patent Proliferative endometrium No Proliferative  endometrium. 
15 G69 Thickened  endometrium N Patent Secretory endometrium No Secretory  endometrium 
16 G146 Endometrium  
hyperplasia 
N Patent Hyperplastic endometrium Yes Complex hyperplasia 
17 G163 N N Patent Proliferative endometrium No Proliferative et with simple  hyperplasia 
18 G162 N N Patent Hyperplastic endometrium  No Secretory et with simple hyperplasia 
19 G183 N N Patent Atrophic endometrium No Atrophic endometrium 
20 G326 Ovarian cyst N Flimsy 
adhesions 
Proliferative endometrium No Proliferative  endometrium 
21 G348 Submucous myoma N Patent Submucous myoma  No Leiomyoma with secretory endometrium 
22 G346  Submucous fibroid N Patent Submucous fibroid No Leiomyoma with secretory endometrium 
23 G407 Endometrium  
hyperplasia 
N Patent Hyperplastic endometrium No Simple hyperplasia 
24 G441 Thickened  endometrium N Patent Secretory endometrium No Secretory  endometrium 
25 G436 N N Patent Proliferative endometrium No Late proliferative endometrium 
26 G435 N N Patent Proliferative endometrium No Lateproliferative 
27 G528 N N Patent Hyperplastic endometrium Yes Complex hyperplasia 
28 G559 Bulky uterus N Patent Hyperplastic endometrium No Proliferative endomerium 
29 G560 N N Patent Atrophic endometrium No Atrophic endometrium 
30 G720 Thickened  endometrium N Patent Submucous myoma  No Leiomyoma with late proliferative 
endometrium 
31 G815 Submucous myoma N Flimsy 
adhesions 
Submucous myoma No Leiomyoma with secretory endometrium 
32 G854 Intramural myoma N Patent Hyperplastic endometrium No Secretory endometrium 
33 G912 N N Patent Proliferative endometrium No Late proliferative  endometrium 
34 G923 N N Patent Proliferative endometrium No Late proliferative endometrium 
35 G1073 Bulky uterus N Patent Secretory endometrium No Simple hyperplasia 
36 G1015 Thickened  endometrium N Patent Proliferative endometrium No Proliferative endometrium 
37 G1014 N N Patent Secretory endometrium No Secretory endometrium 
38 G1065 N N Patent Proliferative endometrium No Late proliferative  endometrium 
39 G1088 Hypernplastic  
endometrium 
N Patent Hyperplastic endometrium No Simple  hyperplasia 
40 G1126 Hyperplastic  
endometrium 
N Patent Submucous myoma No Leiomyoma with adenomyosis 
41 G1172 Bulky uterus N Patent Secretory endometrium No Secretory endometrium 
42 G1264 Ovarian cyst N Patent Proliferative endometrium No Proliferative endometrium 
43 G1306 N N Patent Atrophic endometrium No Atrophic endometrium 
44 G1305 N N Patent Proliferative endometrium No Late proliferative endometrium  
45 G1307 Thickened  endometrium N Patent Hyperplastic endometrium No Simple  hyperplasia 
46 G1304 N N Patent Secretory endometrium No Secretory endometrium 
47 G1318 Bulky uterus N Patent Proliferative endometrium No Proliferative endometrium 
48 G1324 N N Patent Hyperplastic endometrium No Secretory et with simple hyperplasia 
49 G1328 Hyperplastic  
endometrium 
N Patent Submucous myoma No Leiomyoma with late proliferative 
endometrium 
50 G1336 Submucous myoma N Flimsy 
adhesions 
Submucous myoma No Leiomyoma with secretory endometrium 
